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CHAPTER I
Introduction
The development of high-throughput genotyping technologies has revolutionized
the process of identifying disease-predisposing genetic variants. In particular, the vast
quantities of genotype and DNA sequence data generated by these technologies have
enabled geneticists to closely examine statistical correlations between genetic mark-
ers and common complex traits via genome-wide association (GWA) studies. Since
their inception in 2005 (e.g., Klein et al., 2005), GWA studies have identiﬁed over
4,900 single-nucleotide polymorphism (SNP) loci associated with common diseases
and other complex traits (Hindorﬀ et al., 2009, 2011). Some of these association
signals have led to the discovery of previously unsuspected etiological pathways for
common diseases, thereby uncovering potential molecular targets for therapeutic ap-
plications (e.g., Montes et al., 2009; Klionsky, 2009; Yano & Kurata, 2009). However,
most currently known genes that underlie the predisposition to complex diseases were
discovered primarily through studies of European populations, which contain only a
subset of human genetic variation. Worldwide diﬀerences in frequencies of disease
alleles, eﬀect sizes of risk variants, and occurrences of rare variants can aﬀect the
detectability and importance of risk-modifying genes in diﬀerent populations (Rosen-
berg et al., 2010). Thus, questions have arisen about the generalizability of existing
GWA ﬁndings across populations of diverse ancestry.
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Expanding the search for genes that inﬂuence human diseases from European to
non-European populations addresses the extent to which current GWA discoveries are
generalizable to worldwide human populations (Need & Goldstein, 2009; Rosenberg
et al., 2010; Bustamante et al., 2011). Such an expansion provides a mechanism to
prioritize the discoveries for an evaluation of their diagnostic and prognostic potential,
and helps to identify promising genetic variants that aﬀect multiple populations of
diﬀerent ancestry. Additionally, risk variants may have diﬀerent eﬀect sizes or allele
frequencies across populations, suggesting that diﬀerent determinants of the same
disease may exist in diﬀerent populations (Tang, 2006; Adeyemo & Rotimi, 2010). In
the case in which GWA discoveries are unlikely to be generalizable across populations,
the search for risk-promoting genes speciﬁc to particular populations is warranted,
in order to contribute toward alleviating the disease burden in those populations.
Finally, as large-scale genetic studies begin to produce clinically actionable results,
it is important to ensure that populations of diverse ancestry are included in such
studies to avoid exacerbating health-care disparities (Need & Goldstein, 2009).
A recent advance—genotype imputation (Nicolae, 2006; Li et al., 2006; Browning
& Browning, 2007; Marchini et al., 2007; Servin & Stephens, 2007)—holds one of the
keys for expanding the collection of disease-association signals initially detected in
European populations. Genotype imputation is a statistical approach that leverages
high-resolution genetic data from reference datasets to predict genetic variants at
marker positions not directly measured in a particular GWA study. This prediction,
or imputation, both increases the number of markers that can be directly tested
for disease associations and enables the integration of datasets from multiple GWA
studies. Thus, imputation has the potential to increase the statistical power to detect
disease-susceptibility genes and to facilitate statistically robust identiﬁcation of these
genes through larger sample sizes.
Crucial to the success of imputation procedures is the representation of the popula-
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tion under consideration in reference datasets that contain “template” sequences from
which missing genotypes in GWA samples are inferred (Egyud et al., 2009; Huang
et al., 2009a; Pas¸aniuc et al., 2010; Shriner et al., 2010). However, large-scale genomic
datasets, such as those from the International HapMap Project (2005; 2007; 2010)
and the 1,000 Genomes Project (2010), only exist for a limited number of populations.
One way of aiding the search for complex-disease genes in many non-European pop-
ulations for which reference datasets do not exist is to employ innovative imputation
strategies based on statistical and population-genetic principles.
This dissertation centers on developing genotype-imputation strategies that opti-
mize the use of existing genomic resources for genetic studies of complex diseases in
diverse human populations. In Chapters II (Huang et al., 2009a) and III (Huang et al.,
2009b), I pursue the following objectives: (1) I evaluate the portability of existing
genomic resources for imputation-based GWA studies in 29 worldwide populations;
(2) I identify the optimal combinations or mixtures of existing reference datasets for
enhancing imputation in these diverse populations; and (3) I quantify the increase
in the minimal sample size, due to imperfect imputation, that would be required
to provide the same level of statistical evidence of disease predisposition for genetic
variants that are imputed, rather than directly measured, in the 29 populations.
To achieve these objectives, I use genotype data on over 500,000 genetic markers
in 443 individuals from 29 diverse human populations, as well as data on nearly two
million genetic markers in 210 individuals from three reference populations. Through
a series of imputation experiments, I ﬁnd that African populations are generally the
most diﬃcult to impute accurately. Moreover, I ﬁnd that nearly all populations ben-
eﬁt from the use of a mixture approach that I develop for selecting appropriate panels
of reference data. Considering a simple 2 × 3 chi-squared test and the distribution
of its non-centrality parameter, I next estimate the adjustments in the minimal sam-
ple size required to detect disease associations, at imputed versus directly measured
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markers. Surprisingly, I ﬁnd that even a 1% increase in imputation error can lead to a
substantial increase (5-13%) in the sample size required for detecting risk-enhancing
SNPs that are imputed. These results imply that advanced statistical and computa-
tional approaches that decrease imputation error can substantially reduce the sample
sizes needed for imputation-based detection of genetic variants that underlie complex
human diseases.
In agreement with observations from other studies of genotype imputation in glob-
ally distributed human populations (Guan & Stephens, 2008; Pei et al., 2008; Huang
et al., 2009a, 2012; Li et al., 2009; Fridley et al., 2010; Surakka et al., 2010), Chapters
II and III also demonstrate that imputation accuracy varies across populations and
that population-genetic factors play a role in determining the level of imputation ac-
curacy attainable in a particular population. However, it has been unclear how these
factors, such as the overall level of linkage disequilibrium in a population targeted
for imputation and the degree of genetic similarity between the target and candi-
date reference populations, inﬂuence imputation accuracy. In Chapters IV (Huang
et al., 2012) and V, using empirical data and coalescent theory, respectively, I pro-
vide detailed investigations of the relationship between population-genetic factors and
imputation accuracy.
In Chapter IV, using genotype data in 253 individuals from 15 Sub-Saharan
African populations and in 901 individuals from 11 reference populations, I study
how genotypic and haplotypic variation in population pairs containing a target popu-
lation and a reference population aﬀect imputation accuracy in the target population.
I ﬁnd that simple summary statistics of population diﬀerentiation, such as Fst between
target and reference populations, correlate well with imputation accuracy. Thus, I
recommend their use for predicting the optimal reference panel among a collection
of candidate panels for imputation in the target. Furthermore, extending the inves-
tigation to an additional 854 individuals from 48 populations worldwide, I observe a
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pattern in imputation accuracy that is consistent with models of out-of-Africa migra-
tions of modern humans. Under these models, haplotype diversity is predicted to be
greatest in Africa, potentially explaining the observation that imputation accuracy
is higher when imputing untyped markers in a non-African population on the basis
of an African population than when performing imputation in the reverse direction.
Encouraged by the potential of population-genetic models to clarify the determinants
of imputation accuracy, I next develop a population-genetic modeling framework to
study genotype imputation.
In Chapter V, using a two-population demographic model in which a pair of
populations diverged at some time in the past, I derive the approximate expectation
and variance of imputation accuracy in a target sequence sampled from one of the
two populations, using reference sequences sampled either from the same population
as the target sequence or from the other population. I analytically show that under
this model, imputation accuracy—as measured by the proportion of polymorphic sites
that are imputed correctly in the target sequence—increases in expectation with the
mutation rate, with the proportion of the markers in a chromosomal region that are
genotyped in the target, and with the time to divergence between the target and
reference populations. Each of these eﬀects is likely to derive from an increase in
information available for determining the reference sequence that is genetically most
similar to the sequence targeted for imputation. I further analyze as a function of
the divergence time the expected gain in imputation accuracy in the target using a
reference sequence from the same population as the target rather than from the other
population. I ﬁnd that this expected gain in accuracy can be approximated with a
simple expression consisting of quantities that describe the underlying genealogical
relationship between target and reference sequences.
The research presented in this dissertation focuses on the development and appli-
cation of genotype-imputation strategies for association studies of complex diseases
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in diverse human populations. The ﬁrst two published chapters are among the ﬁrst
attempts to oﬀer recommendations on the design of reference panels for imputation-
based genomic studies that seek to identify disease-predisposing genes in worldwide
human populations. These study-design recommendations help address an important
current issue in human genetics: whether disease ﬁndings obtained from European
populations are generalizable to populations around the globe (Need & Goldstein,
2009; Rosenberg et al., 2010; Bustamante et al., 2011). The latter two chapters ex-
plore the empirical and theoretical basis for the ways in which population-genetic
factors inﬂuence imputation accuracy. The results from these chapters provide in-
sights on ways to improve forthcoming GWA analyses in some of the most genetically
diverse human populations, such as those from Africa. Overall, this dissertation will
facilitate future association studies in populations of diverse geographical origins, con-
tributing to the mapping of genetic determinants of complex diseases for the human
species as a whole.
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CHAPTER II
Genotype Imputation Accuracy across Worldwide
Human Populations
2.1 Introduction
The recent availability of high-density single-nucleotide polymorphism (SNP) geno-
type databases from several human populations has facilitated the mapping of com-
plex disease loci in genome-wide association (GWA) studies. These databases, such as
The International HapMap Project (2.5 to 4 million SNPs genome-wide; 2005; 2007)
and SeattleSNPs (∼7 Mb of resequencing data in genes), provide high-resolution in-
formation about allele frequencies and patterns of linkage disequilibrium (LD) among
SNPs typed in the samples. They serve as “reference panels” useful for diverse pur-
poses in human genetics.
Information in reference panels can be leveraged in a mapping context by merging
the reference genotype data with collections of data from individual GWA studies
(Figure 2.1). Because typical GWA studies contain genotype data on, at most, a few
hundred thousand to a million SNPs, a very speciﬁc missing data pattern emerges
from the union of a reference panel with a GWA data set. That is, for most SNPs,
observations exist for the reference panel but not for the GWA study (Figure 2.1d).
By modelling the pattern of LD in the reference panel, and then applying the ﬁtted
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model to the observed GWA study data, the “missing” GWA SNP genotypes can
be eﬀectively imputed (Li et al., 2006; Nicolae, 2006; Marchini et al., 2007; Servin
& Stephens, 2007; Yu & Schaid, 2007; Browning, 2008; Guan & Stephens, 2008).
Imputed genotypes at these SNP loci can then be used to test for association with
disease in the same way that testing occurs for SNPs that were actually genotyped
in the GWA study.
To date, most GWA studies have been conducted in populations that are well-
represented by the available high-density reference panels. Speciﬁcally, study samples
have typically derived from populations of northern European ancestry, for which the
HapMap CEU panel – based on individuals of northern and western European descent
sampled in Utah – has provided additional information for imputation in association
testing (Scott et al., 2007; Wellcome Trust Case Control Consortium, 2007; Reiner
et al., 2008; Willer et al., 2008). However, for the purpose of genotype imputation, it
is unclear how well the HapMap panels represent the patterns of genetic variation in
other populations, particularly those that are more distant from the available panels,
either in terms of demographic history or in terms of geographic proximity. Here we
attempt to evaluate the “portability” of these panels for imputation-based studies
of diverse human populations; this work is analogous to recent assessments of the
portability of informative SNPs chosen from reference panels in providing LD-based
genomic coverage in diverse populations (Conrad et al., 2006; Gonza´lez-Neira et al.,
2006; Gu et al., 2007, 2008; Xing et al., 2008).
Recently two studies examined patterns of SNP variation in multiple human pop-
ulations from around the world, providing data on samples from the Human Genome
Diversity Project (HGDP) at more than 500,000 SNPs (Jakobsson et al., 2008; Li
et al., 2008). We select one of these databases (Jakobsson et al., 2008) and in sev-
eral ways we evaluate the behavior of a missing data imputation algorithm in each
of the sampled populations. First, using the sampled populations alone, we assess
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average imputation accuracy when imputing masked genotypes in the absence of a
reference panel (Figure 2.1a). Second, we use the European American (CEU), Yoruba
(YRI), and combined Chinese and Japanese (CHB+JPT) panels from the HapMap
project in various combinations as reference panels, and we evaluate the properties of
imputation in the sampled populations using the reference panel data (Figures 2.1b
and 2.1c). Finally, using data from a targeted high-density scan of several genomic
regions on chromosome 21 in the HGDP samples (Conrad et al., 2006; Pemberton
et al., 2008), we also assess the accuracy with which genotypes of untyped markers
can be imputed in these populations from the ∼500,000 typed SNPs and various
combinations of HapMap reference panels (Figure 2.1d).
We ﬁnd that when employing HapMap reference panels for imputation, genotypes
from European HGDP samples are imputed with the highest accuracy, followed by
samples from East Asia, Central/South Asia, the Americas, Oceania, the Middle
East, and Africa. The choice of preferred HapMap reference panels for imputation in
populations worldwide follows major geographic groupings. For most HGDP popu-
lations, we obtain additional gains in imputation accuracy when imputing genotypes
based on a mixture of available reference panels. These ﬁndings can serve as a basis
for the application of imputation methods to analysis of genomic data in populations
worldwide.
2.2 Materials and Methods
2.2.1 Data
We examined a subset of 443 unrelated individuals from 29 populations in the HGDP-
CEPH Human Genome Diversity Cell Line Panel, a worldwide collection of individ-
uals from diverse locations (Cann et al., 2002). Individual genotypes obtained using
the Illumina HumanHap550 SNP platform had been previously reported by Jakobs-
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son et al. (2008) at 513,008 biallelic autosomal genetic markers (246 SNPs ultimately
discarded by Jakobsson et al. (2008) to produce their ﬁnal data set of 512,762 SNPs
were included here as potentially informative for imputation).
For some analyses, we incorporated additional individuals to serve as reference
data for imputing missing genotypes. The reference data consisted of phased hap-
lotypes of 210 individuals from the International HapMap Project (2005; 2007): 60
European Americans sampled from Utah, USA (abbreviated CEU), 60 Yoruba indi-
viduals from Ibadan, Nigeria (YRI), 45 Chinese from Beijing, China, and 45 Japanese
from Tokyo, Japan (CHB+JPT). The phased HapMap data (release 21) were down-
loaded from the HapMap phase II data website (see Web Resources). The CHB and
JPT haplotypes were combined into a single panel, and the speciﬁc origins of individ-
ual haplotypes (either CHB or JPT) were ignored. The CEU and YRI sets consisted
of parents from trios; the oﬀspring were omitted from our study but had been used
in inferring haplotypes in the parents. A total of 1,958,375 autosomal markers poly-
morphic in the set of 210 HapMap individuals were used in our analyses. All except
two of these SNPs (rs7008731 and rs13332778) were separately polymorphic in the
CEU, YRI, and CHB+JPT panels.
In some analyses, we used data from Conrad et al. (2006), where some of the
genotypes imputed with the data of Jakobsson et al. (2008) were measured directly
in the same HGDP samples. These analyses used an updated version of the Conrad
et al. (2006) data from Pemberton et al. (2008).
2.2.2 LD-based Imputation
Multiple models exist for accurate imputation of missing genotypes based on LD
information (Nicolae, 2006; Marchini et al., 2007; Servin & Stephens, 2007; Browning,
2008; Stephens & Scheet, 2005; Scheet & Stephens, 2006; Browning & Browning,
2007; Lin et al., 2008). For our investigations of variation in genotype imputation
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accuracy across populations, we used a recent implementation of a model related
to the approach of Li & Stephens (2003), namely the Markov Chain Haplotyping
algorithm (MACH-1.0.15) of Li et al. (2006); see Web Resources.
The intuition underlying this imputation approach is that collections of individu-
als, even those who are “unrelated,” share short stretches of DNA sequence derived
identically by descent from their common ancestors. Once these stretches are iden-
tiﬁed using a set of SNPs, it is possible to probabilistically predict alleles for inter-
vening SNPs that are not measured in a given individual but that are measured in
other individuals. Using a hidden Markov model, the algorithm resolves a collection
of unphased genotypes into imperfect mosaics of several “template” haplotypes, from
which it obtains an imputation or a best guess of each unknown genotype in each
individual under consideration. All of our analyses rely on these “best guess” impu-
tations, ignoring uncertainty in the genotype estimates. Exact software settings are
given in the appendix.
2.2.3 Inferring Missing Genotypes without Additional Reference Individ-
uals
To assess the impact of the proportion of missing genotypes on imputation accuracy
in each population, we masked a fraction of the genotypes at random, and we then
compared the estimated genotypes to the actual, masked genotypes (Figure 2.1a).
The proportion of missing genotypes was varied between 5% and 50% with a 2.5%
increment. That is, each diploid genotype was masked independently with probability
equal to the speciﬁed proportion of missing genotypes. The proportion of correctly
imputed alleles is reported as “imputation accuracy” throughout our analyses. For
example, if the correct genotype was homozygous at a locus for a particular individual
and a heterozygous genotype was imputed, then the algorithm was viewed as having
produced 1 of 2 correct alleles. Similarly, if the algorithm imputed a homozygous
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genotype at a locus where the correct genotype was heterozygous, then we considered
the algorithm to have produced 1 of 2 correct alleles. It follows that the maximal
number of alleles possible to impute incorrectly was 2 when the unknown genotype
was homozygous and 1 when the unknown genotype was heterozygous.
In each of the 29 population samples, we measured the imputation accuracy for
each proportion of missing genotypes, averaging across all markers. We summarized
imputation accuracy genome-wide by the weighted average of chromosome-speciﬁc
imputation accuracy, using the numbers of SNPs on individual chromosomes as the
weights. In our analysis of the role of the proportion of missing genotypes, an indi-
vidual’s missing genotypes were estimated based on information strictly from other
individuals in the same population sample. To obtain comparable results across pop-
ulations, we restricted our analyses to a sample size of six individuals per population,
the smallest sample size among the 29 populations. For each population, the six
individuals were chosen randomly.
To evaluate the eﬀect of sample size on imputation accuracy, we generated sub-
samples for each population and each sample size by sequentially removing individuals
one at a time from the full sample. To ensure that random sub-samples of individuals
were used in the evaluation of imputation accuracy in each population, each of the
population samples was permuted prior to the construction of sub-samples. In each
data set, genotypes were hidden with a proportion of missing genotypes equal to 15%,
and missing genotypes were estimated by MACH. We assessed imputation accuracy
for various sample sizes for each population, and again summarized it by the weighted
average allelic imputation accuracy across autosomes. As imputation accuracy varies
across individuals in a population, the sequence in which individuals were removed
from a full population sample could conceivably inﬂuence the relationship between
imputation accuracy and sample size. Therefore, to examine the importance of the
particular sequence of individuals utilized in the estimation procedure, we repeated
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the analysis using a second randomly chosen sequence of individuals in each popu-
lation. Diﬀerences in imputation accuracy from the two sequences (i.e., imputation
accuracies based on the ﬁrst permuted sample minus corresponding values based on
the second permuted sample) were negligible for most populations and sample sizes
(Figures S2.1 and S2.2).
2.2.4 Inferring Missing Genotypes with Additional Reference Individuals
2.2.4.1 Imputation Accuracy versus Panel Size
Using a single HapMap panel (either the CEU, YRI, or CHB+JPT sample) as a
reference group to infer missing genotypes (Figure 2.1b), we investigated the rela-
tionship between imputation accuracy and reference panel size. For each HapMap
panel, we permuted the panel and constructed random sub-panels of size 10, 20, . . . ,
120 haplotypes by sequentially adding 10 haplotypes in the order speciﬁed by our
permutation. Note that each of the resulting sub-panels, when viewed independently,
represented a random sample of haplotypes from the appropriate HapMap panel, and
a consecutive pair of haplotypes did not necessarily correspond to two haplotypes of
the same individual. To obtain comparable results across HapMap panels, we consid-
ered (only in this analysis) sub-panels of size at most 120 haplotypes, despite the fact
that the CHB+JPT panel had size 180 haplotypes. In all populations, we utilized
the same set of sub-panels derived from the HapMap samples for imputation. Based
on each reference panel and its sub-panels, we performed genotype imputation and
evaluated the accuracy across various sizes for a given reference panel as well as across
reference panels for a given size. This analysis used the full sample from each HGDP
population.
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2.2.4.2 Imputation Accuracy versus Panel Composition
In addition to assessing imputation accuracy using each of the three HapMap panels
in isolation, we also considered the panels combined together, and we considered
other mixtures of the various panels (Figure 2.1c). To identify the mixture that
produced the maximal imputation accuracy, we imputed missing genotypes in each
population using mixed reference samples formed by combining individuals from the
three HapMap groups. In contrast to our previous analyses, in which we considered
missing genotypes on the entire autosomal genome, in this analysis we imputed only
unknown genotypes on one chromosome, chromosome 2, in the interest of reducing
computation time. We considered a variety of mixtures, with each mixture consisting
of combinations of HapMap reference haplotypes chosen according to a speciﬁed ratio.
For each ratio, we used a reference panel of maximal size, constrained by the
fact that most ratios involving two or more reference panels do not permit use of all
available haplotypes from the panels under consideration. The set of mixtures that
we considered corresponded to the set of vectors (i1, i2, i3) of nonnegative integers
with i1 + i2 + i3 = 7. For each vector, we constructed a mixture sample consisting
of a1 CHB+JPT haplotypes, a2 CEU haplotypes, and a3 YRI haplotypes, so that a1,
a2, and a3 were as large as possible and so that they satisﬁed a1 : a2 : a3 = i1 : i2 : i3.
For example, the vector (i1, i2, i3) = (4, 2, 1) led to (a1, a2, a3) = (180, 90, 45).
In each population, using all individuals sampled from the population, we assessed
imputation accuracy using each of 36 mixed collections of haplotypes from the three
HapMap panels (corresponding to the 36 solutions to i1 + i2 + i3 = 7). For each
(i1, i2, i3), within HapMap groups, haplotypes were chosen randomly among the hap-
lotypes present, and the same randomly chosen subsets of the three HapMap panels
were used as the reference panel in all HGDP populations. The random sets of hap-
lotypes were chosen so that if h haplotypes from a HapMap population were used in
one mixed collection and h′ > h haplotypes from the same HapMap population were
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used in another mixed collection, then it was always true that the set of h haplotypes
comprised a subset of the set of h′ haplotypes. For (i1, i2, i3) given, the solution for
the number of haplotypes, (a1, a2, a3), was obtained as described in the appendix.
2.2.5 Application to Untyped Markers
In current GWA studies, genotypes are collected at densities on the order of ∼500,000
SNPs genome-wide. In such a study, by using a reference panel, additional informa-
tion can be obtained about the genotypes of SNPs not typed directly in the GWA
study but measured in an external reference panel. To assess the accuracy with
which the genotypes of these markers can be imputed, we used the 513,008 SNPs
typed in samples from 29 populations (Jakobsson et al., 2008) in combination with
the HapMap reference panels to impute genotypes of 1,445,367 SNPs. We then com-
pared the imputed genotypes to those measured directly by Conrad et al. (2006) and
updated by Pemberton et al. (2008), which, for limited regions of the genome, consist
of SNPs at higher density than in a typical GWA study. Using this protocol, we
assessed imputation accuracy at 218,345 diploid genotypes, as described below. We
note that in contrast with our other analyses, in which genotypes were imputed in
randomly chosen SNP positions that varied across individuals, in this analysis, for
certain markers genotyped only in the reference panel, the genotypes of all individu-
als in the study sample were imputed. To distinguish this scenario from the “missing
genotypes” scenarios of our other analyses, we refer to such markers as “untyped
markers.”
Among the 2810 SNPs reported by Pemberton et al. (2008), 1272 were located
on chromosome 21, so we restricted this analysis to chromosome 21 for convenience.
Among these 1272 SNPs, 1008 had not been included in the SNP set studied by Jakob-
sson et al. (2008) Of the 1008 SNPs, 513 were genotyped in the HapMap individuals.
We thus assessed imputation accuracy at these 513 SNPs by using the genotypes at
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6068 SNPs from Jakobsson et al. (2008) and the 26,716 SNPs available on chromosome
21 in the HapMap data. Using the HapMap reference panels to impute genotypes of
untyped markers in all 443 individuals studied by Jakobsson et al. (2008), we mea-
sured imputation accuracy for the 513 SNPs in a set of 426 individuals. This set of
426 individuals is the intersection of the set of 927 unrelated HGDP individuals stud-
ied by Conrad et al. (2006) and Pemberton et al. (2008) with the set of 443 unrelated
HGDP individuals studied by Jakobsson et al. (2008). The set contains at least ﬁve
individuals from each of 29 populations. In total, of the 2(426)(513)=437,076 possible
alleles in which imputation accuracy could be measured, 436,690 alleles were avail-
able (that is, 386 alleles were not reported by Pemberton et al., 2008). As the data of
Pemberton et al. (2008) are based on a set of individuals that overlaps with that of
Jakobsson et al. (2008), this experiment mimics the scenario in which a genotyping
chip is used on a set of samples and imputation of additional genotypes at marker
positions that were not previously typed in the same samples is of interest (Figure
2.1d). This scenario occurs, for instance, in meta-analyses of multiple GWA studies
(Barrett et al., 2008; Lettre et al., 2008; Loos et al., 2008; Zeggini et al., 2008).
In addition to reporting the proportion of alleles estimated correctly as the mea-
sure of imputation accuracy, we also calculated the square of a linear correlation
coeﬃcient between the imputed and directly-measured genotypes. At each SNP for
which the true genotypes were masked, we coded the possible genotypes as 0, 1, or 2,
representing the possible counts of the minor allele at this SNP in the target popula-
tion. Let xi denote the imputed genotype for individual i, and let x¯ denote the mean
value of the imputed genotypes across individuals. Similarly, let gi and g¯ denote the
analogous quantities for the true genotypes. Then, the statistic, r2, is computed as
r2 =
⎛⎝ ∑ni=1 (xi − x¯) (gi − g¯)√∑n
i=1 (xi − x¯)2
∑n
i=1 (gi − g¯)2
⎞⎠2 ,
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where n is the number of individuals in the population sample. This squared corre-
lation coeﬃcient was then averaged across SNPs to obtain a summary measurement
for each population.
2.3 Results
2.3.1 Inferring Missing Genotypes without Additional Reference Individ-
uals
Imputation accuracies for each population, as a function of the proportion of missing
data, are displayed in Figure 2.2. Here, no reference panel has been used, and we
observe a decrease in accuracy with an increasing proportion of missing data. The
Pima and Colombian groups exhibited the highest imputation accuracies (>92% with
15% of genotypes missing). Across populations, the degree to which the proportion
of missing genotypes aﬀects imputation accuracy is relatively constant, as is evident
in the parallel trajectories across populations in the ﬁgure. Over the range of missing
data proportions examined, we did not observe a qualitative diﬀerence in population
rankings by imputation accuracy. Populations from the Americas and Oceania had
the highest imputation accuracy, followed by populations from Asia and Europe;
African populations had the lowest imputation accuracy. Because the choice of the
proportion of missing genotypes had relatively little inﬂuence on population rankings
by imputation accuracy, especially for proportions less than ∼30%, we proceeded to
subsequent analyses with a single proportion of missing genotypes equal to 15%.
Figure 2.3 shows the relationship between imputation accuracy and sample size,
when unknown genotypes were imputed based only on information from within a
population sample (i.e., without a reference panel). The imputation accuracy, as
measured by the proportion of alleles imputed correctly, increases as sample size
increases. The pattern across populations is similar to that in Figure 2.2, with popu-
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lations from the Americas and Oceania having the highest imputation accuracy and
African populations having the lowest imputation accuracy. The boost in accuracy
provided by increasing the sample size is greatest when the sample size is small.
To assess the importance of the particular sequence of individuals employed in
evaluating the role of sample size, for each population sample we used an additional
random ordering of individuals. Figure S2.1 shows the imputation accuracy as a
function of sample size in the absence of a reference panel for each of two sets of
permuted samples. The point-wise diﬀerences between the values in the two plots
in Figure S2.1 are shown in Figure S2.2, which displays no systematic diﬀerence in
imputation accuracy as a function of sample size between the two permuted samples.
The maximal diﬀerence in imputation accuracy between the two permuted samples
was less than 0.5% in most populations. Consequently, the impact of using a partic-
ular sequence of individuals in the evaluation of imputation accuracy appears to be
minimal.
2.3.2 Inferring Missing Genotypes with Additional Reference Individuals
2.3.2.1 Imputation Accuracy versus Panel Size
Figure 2.4 shows the relationship between imputation accuracy, based on each of
the three HapMap reference panels, and the size of the panels. In the ﬁrst three
columns, we plot the imputation accuracy from inference of missing genotypes in each
population, based on a single HapMap panel. In the ﬁnal (rightmost) column, we plot
the maximal imputation accuracy for each population, taken point-wise from the ﬁrst
three columns. Generally, when we used a single HapMap reference panel, higher
imputation accuracies occurred in populations from the same geographic region as
the reference panel and lower imputation accuracies occurred in African populations.
With the YRI sample as the reference panel, both the highest and lowest imputation
accuracies occurred in populations from Africa (Yoruba and San, respectively).
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We generally observed increasing imputation accuracy with increasing reference
panel size. Averaging across all 29 populations and all three HapMap reference panels,
the increase in imputation accuracy was 3.21% when the reference panel size increased
from 10 to 20 haplotypes; for subsequent additions of 10 reference haplotypes, the
associated increases were 1.06%, 0.56%, 0.35%, 0.23%, 0.18%, 0.13%, 0.11%, 0.10%,
0.07%, and 0.06%. When we used the HapMap CEU or CHB+JPT sample as the
reference panel, the imputation accuracy appeared to reach a plateau as the reference
panel size approached 120 haplotypes. However, we did not observe as clear a plateau
when using the HapMap YRI sample as the reference panel, particularly for the
Yoruba HGDP sample.
When we considered the maximal imputation accuracy attained by using a single
HapMap reference panel of size 120 haplotypes, European populations generally had
the highest accuracy, followed by populations from East Asia, Central/South Asia,
the Americas, the Middle East, Oceania, and Africa (Figure 2.4). The maximal impu-
tation accuracies of populations within a geographic region displayed more variation
in Africa and the Middle East than in other geographic regions. For example, when
using 120 haplotypes from the reference panel, we found that African and Middle
Eastern populations had a wider range of maximal imputation accuracies (9.8% for
African populations and 2.8% for Middle Eastern populations) than, for instance, the
Central/South Asian populations (<1% between the highest and lowest accuracies).
Figure 2.5 summarizes with a bar plot the maximal imputation accuracy achieved
by one of the HapMap reference panels, each of size 120 haplotypes, for each popu-
lation. The colors of the bars indicate which HapMap panel was utilized to produce
the maximal imputation accuracy. In African populations, we obtained the maximal
imputation accuracy using the HapMap YRI sample as the reference panel. Pop-
ulations from Europe, Central/South Asia, and the Middle East as well as Maya
from the Americas attained their maximal imputation accuracies using the HapMap
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CEU panel, whereas populations from East Asia and Oceania as well as Pima and
Colombian from the Americas achieved their maximal accuracies with the HapMap
CHB+JPT reference panel.
2.3.2.2 Imputation Accuracy versus Panel Composition
For each population, Figure 2.6 displays the imputation accuracy based on mixtures
of HapMap reference panels, indicating with a darkened circle the mixture of HapMap
samples that produced the maximal imputation accuracy. The vertices of a triangle
in Figure 2.6 represent imputation accuracies based solely on a single HapMap group,
and the interior points represent imputation accuracies achieved by using mixtures of
HapMap reference haplotypes (see Materials and Methods). The colors correspond
to the nine quantiles of the observed imputation accuracies across all mixtures and
all populations, with darker colors representing higher imputation accuracies. Each
point in a triangle is colored according to the imputation accuracy produced by the
panel mixture corresponding to the point.
With only a few exceptions, the panel mixture that led to the maximal imputation
accuracy for a particular population had as its primary component the same HapMap
reference panel that produced the maximal imputation accuracy individually in Figure
2.5. Speciﬁcally, the YRI panel was the primary component of the mixture for all
African populations, the CEU panel was the primary component for all European
populations, and the CHB+JPT panel was the primary component for populations
from East Asia, Oceania and the Americas. However, populations from the Middle
East and Central/South Asia did not display such homogeneous patterns for the
major contributing HapMap panel in the optimal mixture. In two Middle Eastern
groups, Mozabite and Bedouin, the HapMap YRI and CEU samples contributed
equally to their optimal mixtures of reference haplotypes, while in the other two
Middle Eastern groups, Palestinian and Druze, the CEU sample alone served as the
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major contributing HapMap reference panel. For populations from Central/South
Asia, the major contributing HapMap panels were the CEU sample in the Balochi
group and the CHB+JPT sample in the Kalash and Uygur groups; the optimal
mixture for the Burusho group contained equal contributions from the HapMap CEU
and CHB+JPT samples.
Compared with imputation accuracy obtained using only a single HapMap ref-
erence group (Figures 2.4 and 2.5), in 23 of 29 populations, the major contributing
HapMap sample in the mixtures that produced the maximal imputation accuracies
corresponded to the single highest-accuracy panel in the analysis of HapMap panels
individually. In the Kalash, Uygur, and Maya populations, the major contributing
HapMap samples diﬀered from the samples that produced the highest imputation
accuracy when we evaluated HapMap panels separately; the Mozabite, Bedouin, and
Burusho populations each had two HapMap panels contributing the same number of
reference haplotypes in the optimal mixtures.
When we considered imputation accuracy across populations based on the 36
mixtures of reference panels, European and East Asian populations had generally
higher imputation accuracies that fell within the top quantiles. With the exception
of the Yoruba population, African populations had substantially lower imputation
accuracies that mostly fell within the bottom quantiles. The highest imputation
accuracy across all points in Figure 2.6 was 97.83% in the Basque population (based
on a mixture consisting of 48 CHB+JPT haplotypes, all 120 CEU haplotypes, and
no YRI haplotypes). The lowest imputation accuracy accuracy among all points
tested—the minimum value across all 29 × 36 choices of a population sample and a
reference panel—was 78.20%, in the San population (based on the entire CHB+JPT
panel, 180 haplotypes). While the use of mixed reference panels resulted in increased
imputation accuracy in all populations, the choice of all 210 HapMap individuals as
the reference panel did not yield the highest imputation accuracy in any of the 29
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populations. However, this choice generally produced similar imputation accuracy
to that of the optimal mixture; across populations, the mean diﬀerence between
imputation accuracy based on the optimal mixture and that based on the full HapMap
sample was 0.0059. This value was less than the mean diﬀerence between imputation
accuracy based on the optimal mixture and that based on the optimal vertex (0.0079).
2.3.3 Application to Untyped Markers
Figure 2.7 and Table S2.1 present imputation accuracy for inference of unknown
genotypes in the untyped chromosome 21 markers of Jakobsson et al. (2008), based
on individual HapMap panels and on mixtures of two or three HapMap panels. As
indicated by the bar plot in Figure 2.7, ﬁve of seven combinations of HapMap pan-
els produced the highest imputation accuracy in at least one population. The two
combinations that did not serve as the optimal reference panel in any of the popula-
tions were the HapMap CEU sample and the combination of the YRI and CHB+JPT
samples. Except in ﬁve groups (San, Mbuti Pigmy, Yoruba, Mandenka, and Lahu),
most populations we examined beneﬁted from use of a combination of two or more
HapMap samples as the reference panel to impute genotypes at untyped markers on
chromosome 21. The highest maximal imputation accuracy was 96.05%, occurring
in a European population, Adygei, and the lowest maximal imputation accuracy was
89.12%, occuring in an African population, San.
In this setting, where mixtures of HapMap panels are coarser than those displayed
in Figure 2.6, for 11 of 29 populations the imputation accuracy was the highest when
we constructed the reference panel from all available HapMap individuals. Seven of
these 11 groups represent populations of Eurasia with some degree of dissimilarity
from the HapMap groups in northern and western Europe and in China and Japan;
the other four are from Oceania and the Americas.
We obtained comparable results for the choice of reference panel when, in place of
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imputation accuracy, we considered the squared correlation of imputed and measured
genotypes, r2, as a measure of the performance of the genotype imputation procedure
(Figure 2.8 and Table S2.2). Unlike in Figure 2.7, however, populations from the
Americas had the highest values of r2. Across populations, the highest maximal r2,
0.9618, occurred in the Pima population, and the lowest maximal r2, 0.7397, occurred
in the Mbuti Pygmy population. Among the seven combinations of the HapMap pan-
els, the CHB+JPT sample was the only panel that did not serve as the optimal panel
for any of the populations. In 25 of 29 populations, the use of two or three HapMap
samples produced the maximal r2 between the imputed genotypes and those directly
measured by Conrad et al. (2006). A single HapMap panel (YRI) produced the high-
est r2 in San, Yoruba, and Mandenka; another individual panel (CEU) produced the
highest r2 in the Russian population. When we used all available HapMap individuals
as the reference panel, we obtained the maximal r2 in 9 populations, 8 of which were
among the 11 populations for which imputation accuracies were the highest when
using the full HapMap set in Figure 2.7.
2.4 Discussion
Until now, nearly all imputation-based GWA studies have been performed in popu-
lations of European descent. As genotyping costs decrease, such studies will likely
begin to include individuals from an increasing diversity of populations. Due to the
success of recent studies that have leveraged external reference samples for imputation
of unmeasured genotypes and due to the potential we have demonstrated for accurate
genotype imputation in diverse populations, it is likely that the imputation approach
can be applied successfully to GWA studies in which the sampled individuals are
more distantly related to the samples that comprise available reference panels. This
investigation can therefore serve as an initial resource for the design and analysis of
imputation-based GWA studies in these diverse populations.
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We characterized the levels of LD in 29 HGDP populations using the practical
metric of imputation accuracy, the ability to estimate missing genotypes based on pat-
terns of LD. Although our evaluations of imputation accuracy based on the HGDP
samples alone (without using a reference database) are somewhat constrained by the
small sample sizes, we obtained relative imputation accuracies among the HGDP pop-
ulations that reﬂect previously observed levels of LD. For example, these imputation
accuracy comparisons correspond closely to the pairwise LD calculations described by
Jakobsson et al. (2008). Indeed, the Spearman correlation coeﬃcient of population
rankings by imputation accuracy at 15% missing data (Figure 2.2) and population
rankings by the pairwise LD statistic r2 for markers at 10 kb distance (Figure S4 of
Jakobsson et al., 2008) was 0.9680 (Tables 2.1 and 2.2).
Our assessments of which reference panels are most appropriate for imputation
in diﬀerent populations are reminiscent of evaluations of tag SNP portability in the
same populations (Conrad et al., 2006; Gonza´lez-Neira et al., 2006; Pemberton et al.,
2008). When considering the three HapMap samples separately, in nearly all popu-
lations, we obtained the maximal imputation accuracies for the data of Conrad et al.
(2006) and Pemberton et al. (2008) using the same HapMap groups that produced
the highest proportion of variation tagged (PVT) as reported by these studies. The
only exception was the Mozabite population, in which the CEU panel achieved the
highest imputation accuracy and the YRI panel achieved the highest PVT. These
results nonetheless were compatible as both optimal mixtures of HapMap samples in
Mozabites—the one that produced the highest imputation accuracy and the one that
produced the highest PVT (Pemberton et al., 2008)—contained equal proportions of
the HapMap CEU and YRI panels.
More generally, we observed a notable consistency in the PVT and imputation
accuracy results for mixture reference panels. In 24 of 29 populations, the major
contributing HapMap group in the optimal mixture for the purpose of genotype im-
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putation (Figure 2.6) corresponded to the major group in the optimal mixture for
tag SNP selection (Pemberton et al., 2008). In the Burusho population from Cen-
tral/South Asia, the optimal mixture for imputation contained equal HapMap CEU
and CHB+JPT components, whereas the CEU panel alone served as the major con-
tributing HapMap group in the optimal mixture for tag SNP selection (Pemberton
et al., 2008). In the other four populations (Uygur and Kalash from Central/South
Asia and Colombian and Maya from the Americas), the major contributing HapMap
group was the HapMap CHB+JPT panel in the optimal mixture for imputation and
the CEU panel in the optimal mixture for selecting tag SNPs.
Caution needs to be exercised in comparing imputation accuracy results from our
study with tag SNP results from Conrad et al. (2006) and Pemberton et al. (2008).
In our evaluation of the eﬀect of panel size on imputation accuracy using individual
HapMap panels (Figure 2.3), we adjusted for diﬀerences in panel size by studying
HapMap samples of equal size (120 haplotypes), whereas in assessing the potential
of mixture panels to infer unknown genotypes (Figure 2.6), we utilized up to 180
haplotypes from the CHB+JPT reference group to allow for the use of all available
HapMap samples. Pemberton et al. (2008), on the other hand, used subsets of the
CHB+JPT panel of size 120 haplotypes throughout their mixture analyses. Our
decision to utilize the HapMap CHB+JPT panel in its entirety could in part explain
the increased utility of the CHB+JPT panel in the optimal mixtures for the ﬁve
aforementioned Central/South Asian and American populations.
Although LD levels predicted imputation accuracy extremely well when we im-
puted genotypes without reference panels, with reference panels, LD levels were less
predictive of imputation accuracy (e.g., Tables 2.1 and 2.2, Spearman correlation co-
eﬃcient of 0.5795 between the maximal imputation accuracy in Figure 2.6 with the
pairwise LD statistic, r2, at 10 kb). African populations, whose levels of LD were
generally quite similar (Jakobsson et al., 2008), varied considerably in imputation ac-
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curacy, with the highest values occurring in the lower-LD Yoruba population and the
lowest values occurring in the higher-LD Mbuti Pygmy and San populations. Instead
of being highest for populations from the Americas and Oceania, who exhibit the
highest LD levels, in most analyses imputation accuracy was highest for European
and East Asian populations closely related to populations from the reference panels.
When the squared correlation coeﬃcient between imputed and measured genotypes
was used as the measure of imputation performance, however, the rankings of pop-
ulations matched the pattern expected based on LD levels somewhat more closely
(Tables 2.1 and 2.2).
The accuracy with which genotypes can be imputed using a reference panel is
a function of multiple factors, including the similarity of haplotypes in the study
sample and reference panel, as well as the allele frequencies and levels of LD in the
study sample. For most populations in which imputation accuracy was high, the high
value might have been expected on the basis of at least one of these factors. For
the Basque population, who had the highest imputation accuracy in some analyses,
a lower imputation accuracy might have been expected due to the status of the
population as a linguistic isolate. However, previous analyses of the same samples
have found this population to be genetically similar to other European populations,
with similar levels of LD (Jakobsson et al., 2008; Li et al., 2008), so that a similar
imputation accuracy for Basques and other European populations is not surprising.
Another factor that could have contributed to high imputation accuracy in Basques
and other Europeans is the possibility that European reference haplotypes might
have been estimated more accurately than East Asian reference haplotypes, due to
the availability of oﬀspring in trios. Finally, the properties of the markers studied
in the HapMap reference samples might inﬂuence imputation accuracy; many of the
markers used were likely chosen to be informative about LD in Europeans, potentially
leading to increased imputation accuracy in European populations.
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Here we have not extensively examined the ability of LD-based algorithms to
impute genotypes at SNPs of speciﬁc allele frequencies. Our data do, however, permit
a preliminary investigation of the eﬀect of allele frequency on imputation accuracy in
diﬀerent populations. For each population, Figure 2.9 compares imputation accuracy
for untyped markers with minor allele frequency (MAF) greater than 0.2 and untyped
markers with MAF≤0.2. In all 29 populations, the genotypes of markers in the
lower-MAF category were imputed with fewer errors. African populations showed
a high variability in the diﬀerence in imputation accuracy between lower-MAF and
higher-MAF markers (Figure S2.3), with a diﬀerence as high as 8.2% in the San
population. In most non-African populations, genotypes of higher-MAF markers were
imputed almost as accurately as were those of lower-MAF markers—most notably in
the Mozabite population, for whom the diﬀerence in imputation accuracies was only
0.3%. These observations are due, in part, to the distributions of allele frequencies
at the imputed SNPs; populations whose MAF> 0.2 and MAF≤ 0.2 markers had a
larger diﬀerence in mean minor allele frequency (Table S2.3) tended to display larger
diﬀerences in imputation accuracy between the two SNP sets. A larger reference
panel size will be of some help in increasing the potential for accurate imputation;
the extent to which rare alleles are satisfactorily imputed will be more easily tested
in projects that include larger reference sample sizes and, consequently, that include
rarer alleles.
An examination of reference panel size could assist in characterizing the way
in which imputation accuracy changes for alleles in diﬀerent frequency categories
as reference panels are enlarged; we note however that our analysis of imputation
accuracy and reference panel size is restricted to the marker sets directly measured in
the genome scan itself, whereas in practice, the accuracies of all imputed SNPs would
be of interest. Because they were included on a commercial SNP chip, the SNPs
available for testing are tag SNPs that have a somewhat regular spacing. If alleles
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at a tag SNP are masked, then the distance to the nearest tag SNPs from which
the imputation is performed might be greater than the corresponding distance for a
randomly chosen SNP. Additionally, tag SNPs tend to have higher allele frequencies,
at least for the populations in which the SNPs were discovered and the populations
for which the chips were designed. Conclusions about the value of larger reference
panels should be interpreted in this light and might potentially beneﬁt from results
obtained in simulations (Pei et al., 2008).
In evaluating genome-wide imputation accuracies, results from rare SNPs are hid-
den by the large number of testable genotypes at SNPs with more frequent minor
alleles. Furthermore, assessment of imputation accuracy of heterozygous genotypes
at rare SNPs is obscured by the imputation accuracy statistic we use here. For in-
stance, a procedure that always imputes the major allele will, on average, achieve
99.9% accuracy at a SNP with minor allele frequency of 1/1000. However, this high
level of accuracy can hide a high error rate for individuals with the rare allele. As
detection of rare alleles and their interactions becomes more feasible in association
studies, it will be of interest to more carefully assess the accuracy with which rare
alleles can be imputed.
We note that whereas our investigations that did not rely on a reference panel
were aﬀected by the sizes of the HGDP samples, our evaluations of imputation ac-
curacy when utilizing reference panels were not strongly dependent on sample size.
This result is due to the manner in which we conducted our investigations, which
was motivated by current strategies for imputation-based mapping in GWA studies.
Speciﬁcally, conditional on the reference haplotypes, we analyzed the study samples
independently rather than including other study individuals when imputing geno-
types of each particular study individual. Therefore, average imputation accuracies
reported here are unbiased estimates of what would be obtained from studying the
entire population, provided that the individuals chosen were sampled randomly from
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the population.
Because of the conditional independence of study individuals during the analysis
(given the reference haplotypes), the scheme we used to evaluate optimal mixtures
(e.g. Figure 2.6) also mimicked the current setting for analyses of GWA data, where
the information for imputing a single unobserved genotype comes entirely from the
reference panel. Although for this particular investigation, we did not force all geno-
types to be unobserved at speciﬁed loci and instead masked individual genotypes
completely at random, our imputation accuracy results using genotypes masked at
random in Figures 2.4-2.6 were similar to those using completely untyped markers in
Figures 2.7 and 2.8. Results from our detailed investigation of optimal mixtures might
therefore serve as a basis for methods that appropriately weigh reference samples from
the various panels while utilizing all available information.
An alternative approach to evaluating optimal reference panel composition, which
we did not pursue, is to identify the mixture that produced the maximal imputation
accuracy among mixtures of a ﬁxed panel size, in order to more thoroughly evaluate
the maximal imputation accuracy as a function of reference panel size. This approach
is constrained by the diﬀerence in the HapMap reference sample sizes, so it cannot
consider a mixture sample larger than 120 haplotypes (60 individuals), the smallest
HapMap reference panel size. Thus, taking into consideration the eﬀect of reference
panel size on imputation accuracy (Figure 2.4), our use of the largest mixed sample
permitted by a given ratio is motivated by the goal of imputing based on as many
reference individuals as possible, given currently available databases. Although the
optimal mixtures in Figure 2.6 for the 29 populations were not comprised of all 420
haplotypes (from 210 unrelated HapMap individuals), in many cases the diﬀerence
between the maximal accuracy and that obtained from using all haplotypes was rel-
atively small and, for such populations, the collection of all haplotypes would form a
convenient reference.
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2.5 Web Resources
HapMap phase II data,
http://ftp.hapmap.org/phasing/2006-07 phaseII/phased/
MACH software, http://www.sph.umich.edu/csg/abecasis/mach/
Seattle SNPs Variation Discovery Resource, http://pga.gs.washington.edu
2.6 Appendix
2.6.1 Software Settings
The options implemented in MACH that we used included mle, mldetails, interim-
Interval, rounds, errorRate, compact, greedy, autoFlip, and mask. The ﬁrst two
options generate SNP-speciﬁc information (e.g., marker name, allele labels, minor
allele frequency, etc.) as well as genotype-level maximum likelihood estimates of
genotypes, allele dosage, conﬁdence scores, and posterior probabilities for the three
possible genotypes; interimInterval outputs intermediate imputation results; rounds
speciﬁes the number of runs for the Markov sampler (set to 20); errorRate provides to
the algorithm an omnibus measure reﬂecting a combination of genotyping error, gene
conversion, recurrent mutation, and assay inconsistencies between multiple platforms
or laboratories (set to 10−3); compact reduces memory requirements at the cost of
computational time; greedy treats the reference panel (and not the combination of
the study and reference samples) as the only source of reference haplotypes; autoFlip
switches the alleles at a given locus in the study samples to the complementary alle-
les when it is discovered that the reference panel uses alleles A and T and the study
sample uses C and G (or vice versa). The mask option, used throughout our analyses
except in the application to untyped markers, speciﬁes the proportion of genotype
data to be randomly masked for evaluation of imputation accuracy.
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2.6.2 Obtaining Mixtures of HapMap Reference Panels
Here, we solve for the numbers of haplotypes, (a1, a2, a3), that maximize the total
number of haplotypes present when a ratio of integers i1 : i2 : i3 is speciﬁed for the
relative numbers of haplotypes in three groups.
Suppose that positive integers k and n are given, that ij is an integer in [0, k]
for each j from 1 to n, and that
∑n
j=1 ij = k. Suppose also that for each j from
1 to n, a positive integer Aj is given, and aj is an integer in [0, Aj]. We aim to
ﬁnd a = (a1, a2, . . . , an) such that
∑n
j=1 aj is as large as possible and such that
a1 : a2 : . . . : an = i1 : i2 : . . . : in.
Without loss of generality, suppose i1 ≥ i2 ≥ . . . ≥ in. Because a1 : a2 : . . . : an =
i1 : i2 : . . . : in, a1ij/i1 must be an integer for each j. Because
a1ij
i1
=
a1ij/ gcd(i1, ij)
i1/ gcd (i1, ij)
,
where gcd represents the greatest common divisor, for each j, a1 must be a multiple
of i1/ gcd (i1, ij), as ij/ gcd(i1, ij) and i1/ gcd(i1, ij) are relatively prime. It follows
that a1 is a multiple of lcm(i1/ gcd (i1, i2), . . . i1/ gcd (i1, in)), where lcm represents
the least common multiple. Considering that aj = a1ij/i1 and aj ≤ Aj for each j,
a1 ≤ min(A1, A2i1/i2, . . . Ani1/in). As a result, the solution for a1 in the vector a
that maximizes
∑n
j=1 aj is
a1 = lcm
(
i1
gcd(i1, i2)
, . . . ,
i1
gcd(i1, in)
)
×⌊
min(A1, A2i1/i2, . . . Ani1/in)
lcm(i1/ gcd(i1, i2), . . . , i1/ gcd(i1, in)
⌋
. (2.1)
The other components of a are obtained using aj = a1ij/i1.
In our analysis, k = 7, n = 3, and (A1, A2, A3) = (180, 120, 120). For each
(i1, i2, i3) with i1 + i2 + i3 = 7 we obtain (a1, a2, a3) using eq. 2.1. We chose k =
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7 as this is the smallest value that permits use of the full HapMap, at the point
(i1, i2, i3) = (3, 2, 2).
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Figure 2.1: Schematic of experimental designs. The “Study sample” row represents
data used to evaluate imputation accuracy in each design, with SNPs under consid-
eration colored yellow. The “Study sample with missing genotypes” row represents
corresponding data with the unknown genotypes that are imputed colored in red.
The “Reference panel” row represents example reference panels based on which im-
putation of missing genotypes or genotypes of untyped markers is performed. In a
data set, each row corresponds to a haplotype and each column corresponds to a SNP
position. (a) Inference of missing genotypes without additional reference haplotypes.
(b) Inference of missing genotypes with a reference panel of haplotypes from a single
reference sample (either CEU, YRI, or CHB+JPT). (c) Inference of missing geno-
types with a mixture reference panel, formed by taking a speciﬁed ratio of haplotypes
from the HapMap CEU, YRI, and CHB+JPT samples. (d) Inference of genotypes of
untyped markers with a mixture reference panel, formed by combining two or more
HapMap samples. We evaluated imputation accuracy in (a)-(c) for randomly masked
genotypes and in (d) for genotypes of untyped markers.
33
0.
75
0.
80
0.
85
0.
90
0.
95
1.
00
Proportion of missing genotypes
Im
pu
ta
tio
n 
ac
cu
ra
cy
Adygei
Balochi
Bantu (Kenya)
Bantu (S. Africa)
Basque
Bedouin
Biaka Pygmy
Burusho
Cambodian
Colombian
Daur
Druze
Kalash
Lahu
Mandenka
Maya
Mbuti Pygmy
Melanesian
Mongola
Mozabite
Palestinian
Papuan
Pima
Russian
San
Uygur
Yakut
Yi
Yoruba
America
Oceania
East Asia
C/S Asia
Europe
Middle East
Africa
0.1 0.2 0.3 0.4 0.5
Figure 2.2: Imputation accuracy vs. proportion of missing genotypes, in each of 29
populations. This analysis was based on samples of six individuals per population,
and did not use any reference panel.
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Figure 2.3: Imputation accuracy vs. sample size, in each of 29 populations. This
analysis used a proportion of missing genotypes equal to 15%, and did not use any
reference panel.
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Figure 2.5: The maximal imputation accuracy achieved by one of the three HapMap
reference panels, in each of 29 populations, given a proportion of missing genotypes
equal to 15%. This plot corresponds to the imputation accuracy with a reference panel
size of 120 haplotypes in the rightmost column (MAX) in Figure 2.4. For convenience
in interpreting the ﬁgure, the vertical dashed line indicates 90% imputation accuracy.
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Figure 2.6: Imputation accuracy in each of 29 populations achieved by utilizing mix-
tures of HapMap samples chosen according to speciﬁed ratios. Each triangle presents
imputation accuracy, for a given population, based on various mixtures of HapMap
reference panels. The vertices of a triangle represent imputation accuracy based on
a single HapMap group, while the edges and interior points represent imputation
accuracy attained by using mixtures of HapMap reference panels. Darker colors indi-
cate higher imputation accuracy; a darkened circle indicates the maximal imputation
accuracy for a population.
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Figure 2.6: (ﬁgure caption continued from previous page) The spacing of the cutoﬀs
for the various colors was set so that across all 29 populations each color would be
used equally often. The set of mixtures corresponded to the set of vectors (i1, i2, i3)
of nonnegative integers with i1+ i2+ i3 = 7. For each vector, we used as the reference
panel the largest possible mixture sample that consisted of a1, a2, and a3 HapMap
CHB+JPT, CEU, and YRI individuals, respectively, and that satisﬁed a1 : a2 :
a3 = i1 : i2 : i3. Corresponding numbers of HapMap haplotypes in the mixtures,
(a1, a2, a3), are shown in the larger triangle. Imputation accuracy was evaluated
using only chromosome 2, with a proportion of missing genotypes equal to 15%.
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Figure 2.7: Imputation accuracy for inference of genotypes of untyped markers, based
on any one or two or all three HapMap reference panels (with their original size).
The plot on the left shows imputation accuracy based on each of seven choices. The
bar plot on the right represents the maximal imputation accuracy among the seven
choices, and is colored according to the choice of optimal reference panel. For con-
venience in interpreting the ﬁgure, the vertical dashed line indicates 90% imputation
accuracy.
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Figure 2.8: Squared correlation coeﬃcient, r2, between the genotypes imputed from
the data of Jakobsson et al. (2008) and those directly measured in the data of Pem-
berton et al. (2008), based on any one or two or all three HapMap reference panels
(with their original size). The plot on the left shows r2 based on each of seven choices.
The bar plot on the right represents the maximal r2 among the seven choices, and is
colored according to the choice of optimal reference panel. For convenience in inter-
preting the ﬁgure, the vertical dashed line indicates a squared correlation coeﬃcient
of 0.9.
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Figure 2.9: Imputation accuracy for genotypes at untyped markers in the data of
Jakobsson et al. (2008) with minor allele frequency (MAF) greater than 0.2 vs. im-
putation accuracy for genotypes at untyped markers with MAF≤0.2. For a given
population, we separated markers into two categories based on their MAF in the
population, on average placing 220 markers into the lower-MAF category and 293
into the higher-MAF category. Using the imputed genotypes described in Figures 2.7
and 2.8, for each of the seven reference panel choices, we determined the imputation
accuracy, separately restricting our attention to low-MAF markers and to high-MAF
markers. For each population, the highest of these seven numbers for the high-MAF
markers is plotted on the y-axis and the highest of these seven numbers for the low-
MAF markers is plotted on the x-axis (in some cases, the underlying optimal reference
panel diﬀered for the high-MAF and low-MAF markers). The diagonal dashed line
indicates identical imputation accuracy for the two MAF categories. The diﬀerence
between the imputation accuracy of the low-MAF markers and that of the high-MAF
markers is plotted in Figure S2.3.
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Figure S2.3: Diﬀerence in maximal imputation accuracy for two sets of SNPs
(MAF>0.2 and MAF≤0.2), based on data in Figure 2.9. Bars are colored by ge-
ographic locations of the populations.
47
Table S2.1: Imputation accuracy for inference of genotypes of untyped markers in
the data of Jakobsson et al. (2008), based on any one or two or all three HapMap
reference panels (with their original size). These values were used in the scatter plot
of Figure 2.7. For each population, the highest imputation accuracy obtained among
the seven possible reference panels is highlighted in bold.
YRI/ CEU/
YRI CEU CHB+JPT YRI/CEU CHB+JPT CHB+JPT ALL
San 0.8912 0.8226 0.8205 0.8873 0.8873 0.8379 0.8879
Mbuti Pygmy 0.9018 0.8342 0.8224 0.8999 0.8994 0.8411 0.8988
Biaka Pygmy 0.9145 0.8559 0.8459 0.9176 0.9126 0.8629 0.9150
Bantu (Kenya) 0.9360 0.8752 0.8705 0.9396 0.9362 0.8875 0.9382
Bantu (S. Africa) 0.9322 0.8559 0.8536 0.9329 0.9322 0.8647 0.9325
Yoruba 0.9457 0.8667 0.8600 0.9448 0.9437 0.8790 0.9448
Mandenka 0.9419 0.8692 0.8650 0.9414 0.9412 0.8854 0.9408
Mozabite 0.9301 0.9180 0.9032 0.9458 0.9415 0.9226 0.9455
Bedouin 0.9279 0.9407 0.9215 0.9486 0.9421 0.9423 0.9486
Palestinian 0.9342 0.9502 0.9296 0.9550 0.9476 0.9507 0.9543
Druze 0.9300 0.9552 0.9341 0.9562 0.9500 0.9562 0.9569
Basque 0.9337 0.9577 0.9361 0.9570 0.9503 0.9576 0.9579
Russian 0.9338 0.9597 0.9389 0.9590 0.9524 0.9600 0.9599
Adygei 0.9315 0.9593 0.9372 0.9593 0.9512 0.9605 0.9600
Balochi 0.9249 0.9511 0.9337 0.9527 0.9473 0.9516 0.9524
Kalash 0.9165 0.9469 0.9287 0.9488 0.9425 0.9492 0.9477
Burusho 0.9301 0.9487 0.9342 0.9487 0.9465 0.9506 0.9509
Uygur 0.9270 0.9471 0.9427 0.9503 0.9487 0.9537 0.9534
Yakut 0.9249 0.9454 0.9466 0.9468 0.9505 0.9516 0.9513
Mongola 0.9302 0.9444 0.9517 0.9509 0.9545 0.9549 0.9553
Daur 0.9278 0.9434 0.9543 0.9493 0.9552 0.9565 0.9571
Yi 0.9268 0.9431 0.9522 0.9510 0.9533 0.9543 0.9545
Cambodian 0.9301 0.9413 0.9487 0.9455 0.9509 0.9518 0.9511
Lahu 0.9345 0.9480 0.9599 0.9531 0.9598 0.9588 0.9597
Melanesian 0.9207 0.9332 0.9454 0.9471 0.9477 0.9475 0.9497
Papuan 0.9212 0.9268 0.9399 0.9407 0.9436 0.9419 0.9444
Pima 0.9321 0.9487 0.9481 0.9540 0.9552 0.9542 0.9554
Maya 0.9305 0.9539 0.9495 0.9543 0.9558 0.9588 0.9582
Colombian 0.9305 0.9493 0.9398 0.9499 0.9507 0.9517 0.9539
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Table S2.2: Squared correlation coeﬃcient, r2, between the genotypes imputed from
the data of Jakobsson et al. (2008) and those directly measured in the data of Conrad
et al. (2006) and Pemberton et al. (2008). These values were used in the scatter plot
of Figure 2.8. For each population, the highest r2 value obtained among the seven
possible reference panels is highlighted in bold.
YRI/ CEU/
YRI CEU CHB+JPT YRI/CEU CHB+JPT CHB+JPT ALL
San 0.7633 0.6116 0.6200 0.7443 0.7470 0.6416 0.7341
Mbuti Pygmy 0.7340 0.6299 0.6235 0.7397 0.7331 0.6570 0.7346
Biaka Pygmy 0.7804 0.6708 0.6397 0.7882 0.7716 0.6785 0.7795
Bantu (Kenya) 0.8611 0.7178 0.7212 0.8726 0.8553 0.7387 0.8672
Bantu (S. Africa) 0.8452 0.6825 0.6833 0.8510 0.8454 0.6842 0.8492
Yoruba 0.8999 0.7155 0.7049 0.8951 0.8924 0.7350 0.8957
Mandenka 0.8744 0.7087 0.6978 0.8670 0.8731 0.7327 0.8671
Mozabite 0.8541 0.8253 0.7833 0.8959 0.8911 0.8339 0.8973
Bedouin 0.8574 0.8830 0.8296 0.9067 0.8871 0.8843 0.9062
Palestinian 0.8678 0.9015 0.8526 0.9157 0.8984 0.9002 0.9095
Druze 0.8525 0.9107 0.8588 0.9123 0.8943 0.9156 0.9161
Basque 0.8686 0.9240 0.8869 0.9214 0.9023 0.9234 0.9262
Russian 0.8682 0.9310 0.8689 0.9241 0.9093 0.9292 0.9291
Adygei 0.8620 0.9277 0.8749 0.9296 0.9006 0.9307 0.9269
Balochi 0.8614 0.9099 0.8724 0.9175 0.8943 0.9185 0.9155
Kalash 0.8585 0.9058 0.8562 0.9116 0.8931 0.9135 0.9069
Burusho 0.8896 0.9082 0.8699 0.9067 0.9059 0.9127 0.9161
Uygur 0.8675 0.9114 0.8986 0.9175 0.9188 0.9300 0.9282
Yakut 0.8633 0.9036 0.9102 0.9078 0.9205 0.9239 0.9225
Mongola 0.8803 0.9066 0.9212 0.9180 0.9265 0.9236 0.9257
Daur 0.8612 0.8968 0.9289 0.9147 0.9286 0.9300 0.9305
Yi 0.8665 0.8947 0.9127 0.9069 0.9181 0.9199 0.9212
Cambodian 0.8752 0.8858 0.9102 0.8962 0.9156 0.9165 0.9114
Lahu 0.8832 0.8978 0.9332 0.9098 0.9335 0.9291 0.9323
Melanesian 0.8504 0.8597 0.8986 0.9002 0.9035 0.9042 0.9057
Papuan 0.8581 0.8638 0.8796 0.8762 0.8855 0.8884 0.8839
Pima 0.9271 0.9486 0.9423 0.9604 0.9509 0.9572 0.9618
Maya 0.8738 0.9210 0.9146 0.9051 0.9182 0.9243 0.9196
Colombian 0.8858 0.9309 0.9101 0.9209 0.9302 0.9296 0.9331
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Table S2.3: Summary statistics for minor allele frequencies of 513 SNP loci in the
data of Conrad et al. (2006) and Pemberton et al. (2008). The statistics reported here
correspond to those of the marker sets that yielded the imputation accuracy plotted
in Figure 2.9.
All MAF<0.2 MAF≥0.2
Mean Standard Number Mean Standard Number Mean Standard
deviation of
SNPs
deviation of
SNPs
deviation
San 0.1861 0.1639 294 0.0620 0.0672 219 0.3528 0.0912
Mbuti Pygmy 0.1988 0.1521 271 0.0751 0.0616 242 0.3372 0.0921
Biaka Pygmy 0.2270 0.1570 252 0.0886 0.0631 261 0.3607 0.0905
Bantu (Kenya) 0.2474 0.1487 206 0.0925 0.0625 307 0.3513 0.0859
Bantu (S. Africa) 0.2270 0.1445 253 0.1000 0.0707 260 0.3506 0.0731
Yoruba 0.2419 0.1444 213 0.0985 0.0564 300 0.3437 0.0916
Mandenka 0.2370 0.1453 227 0.0998 0.0581 286 0.3460 0.0914
Mozabite 0.2670 0.1259 168 0.1196 0.0521 345 0.3387 0.0807
Bedouin 0.2564 0.1284 179 0.1181 0.0599 334 0.3305 0.0875
Palestinian 0.2539 0.1378 204 0.1159 0.0649 309 0.3450 0.0886
Druze 0.2468 0.1431 200 0.1002 0.0603 313 0.3404 0.0935
Basque 0.2299 0.1503 255 0.1008 0.0602 258 0.3575 0.0923
Russian 0.2235 0.1400 223 0.0935 0.0549 290 0.3235 0.0966
Adygei 0.2383 0.1446 231 0.1016 0.0527 282 0.3502 0.0888
Balochi 0.2459 0.1408 173 0.0877 0.0549 340 0.3264 0.0955
Kalash 0.2490 0.1460 202 0.0959 0.0659 311 0.3484 0.0850
Burusho 0.2628 0.1521 188 0.0882 0.0573 325 0.3638 0.0822
Uygur 0.2636 0.1410 167 0.0961 0.0512 346 0.3444 0.0900
Yakut 0.2383 0.1484 182 0.0692 0.0507 331 0.3313 0.0913
Mongola 0.2507 0.1515 198 0.0903 0.0631 315 0.3515 0.0923
Daur 0.2303 0.1473 206 0.0823 0.0604 307 0.3297 0.0959
Yi 0.2481 0.1541 177 0.0715 0.0585 336 0.3412 0.0967
Cambodian 0.2510 0.1528 216 0.0943 0.0738 297 0.3649 0.0741
Lahu 0.2223 0.1603 261 0.0843 0.0745 252 0.3652 0.0798
Melanesian 0.2155 0.1761 261 0.0589 0.0646 252 0.3777 0.0838
Papuan 0.2113 0.1626 240 0.0590 0.0622 273 0.3453 0.0889
Pima 0.2047 0.1828 237 0.0267 0.0445 276 0.3576 0.0987
Maya 0.2142 0.1633 256 0.0703 0.0656 257 0.3575 0.0878
Colombian 0.2157 0.1617 227 0.0607 0.0599 286 0.3387 0.0991
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CHAPTER III
The Relationship between Imputation Error and
Statistical Power in Genetic Association Studies in
Diverse Populations
The genotype imputation strategy for case-control genetic association studies provides
an economical way of assessing many more genetic markers for disease association
than have actually been measured in any particular association study (Li et al., 2006;
Nicolae, 2006; Marchini et al., 2007; Servin & Stephens, 2007; Browning, 2008). In this
approach, case and control individuals are ﬁrst genotyped for markers densely spread
across the human genome. The genotypes obtained are then combined with high-
resolution genotypic data from genomic databases to impute the genotypic status of
study individuals at markers investigated in the database but not in the study sample.
This imputation relies on the principle that two haplotypes identical in genotype at
nearby SNP markers are likely to share intervening chromosomal stretches identically
by descent. Thus, if a haplotype in a densely genotyped database sample is identical
to a haplotype in a more sparsely genotyped study sample for markers that overlap
between the study and the database, then the study haplotype can be imputed with
high resolution by copying the haplotype from the database.
Partly because they dramatically increase the number of markers that can be di-
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rectly tested for association compared to earlier tag-SNP designs, methods relying on
genotype imputation have proven eﬀective for identifying high-risk disease-associated
genetic variants (Scott et al., 2007; Wellcome Trust Case Control Consortium, 2007;
Barrett et al., 2008; Zeggini et al., 2008; Willer et al., 2008). However, the imputa-
tion strategy utilizes in its association tests estimated genotypes that are not known
with certainty, and errors in imputed genotypes might potentially compromise the
power of an imputation-based association test. For example, at a biallelic marker,
consider a disease-susceptibility allele of small eﬀect that has true frequency 0.3 in
cases and 0.2 in controls. If the probability that imputation recovers the true al-
lele is 0.9, then the frequency of the disease allele among imputed genotypes will be
(0.3)(0.9) + (0.7)(0.1) = 0.34 in cases and (0.2)(0.9) + (0.8)(0.1) = 0.26 in controls.
Imputation error converts an allele frequency diﬀerence of 0.3 − 0.2 = 0.1 between
cases and controls into a smaller diﬀerence of 0.34− 0.26 = 0.08. As a result, for the
imputed genotypes, a larger sample size might be required for determining that allele
frequencies diﬀer between cases and controls compared to the sample size that would
be required if the true genotypes were known.
Although recent studies have found that imputation error rates are generally low
(Yu & Schaid, 2007; Guan & Stephens, 2008; Pei et al., 2008; Zhao et al., 2008; Noth-
nagel et al., 2009), it is possible that even low error rates could have considerable
eﬀects on downstream analyses. How does the error inherent in genotype imputation
reduce the power of an association study when alleles at the true disease SNP are
imputed rather than known? An answer to this question is important to the design
and interpretation of imputation-based association studies. Relating imputation error
and power would assist in calculating sample sizes required for detecting disease vari-
ants at loci whose genotypes are imputed, and for determining if imputation studies
in particular populations are likely to be underpowered. Additionally, a relationship
between imputation error and power would aid in developing resources for genomic
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studies. For example, use of such a relationship could assist in identifying popula-
tions in whom existing resources produce high error rates that limit the potential for
practical mapping of risk variants with imputation strategies.
The problem of connecting imputation error to power is similar to a corresponding
problem in the context of tag SNPs. In the imputation context, the loss of information
due to imputation error at a disease-susceptibility locus can obscure the association
between the locus and disease. In the tag-SNP context, the loss of information due
to use of a tag SNP rather than the true disease SNP has an analogous eﬀect. In
both situations, missing information about the correct genotypes at the true disease-
susceptibility locus contributes to a loss of power to detect disease association.
For the tag-SNP context, consider two loci, a SNP causally associated with disease
and a nearby tag SNP. If the r2 correlation statistic for linkage disequilibrium (LD)
between the tag SNP and the disease SNP is equal to c, then a chi-squared test
statistic for disease association at the true disease SNP in a case-control sample of
total sizeN has approximately the same asymptotic distribution under the alternative
hypothesis of disease association as the corresponding chi-squared statistic at the tag
SNP in a case-control sample of size N/c (Pritchard & Przeworski, 2001). Thus, the
“sample size inﬂation factor” required in using the tag SNP in an association study
rather than the true disease SNP is ∼1/c.
Motivated by this result, multiple versions of an r2 correlation statistic between
the imputed genotypes at a SNP and the true genotypes have been proposed (de
Bakker et al., 2008; Browning & Browning, 2009; Huang et al., 2009a). Such statis-
tics, which are sometimes used to identify markers imputed with high accuracy in
imputation-based GWA studies (Scott et al., 2007; Lettre et al., 2008), have been
viewed as conceptually analogous to the r2 statistic for LD between a tag SNP and a
disease SNP, but have not been shown to be mathematically equivalent to it. In the
imputation context for a biallelic SNP with alleles A and B, the correlation between
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true and imputed genotypes is a function of a 3 × 3 table, in which each of three
possible true genotypes (AA, AB, BB) has one of three possible imputations. In
the tag-SNP context, however, if the disease SNP has alleles A and B and the tag
SNP has alleles C and D, then the corresponding table is 2×2, containing entries for
the counts of the four possible haplotypes (AC, AD, BC, BD). Although the close
analogy between the tag SNP and imputation contexts suggests that the relationship
between imputation error and power is similar to that observed between power and
LD with a tag SNP, at present the connection between imputation r2 statistics and
power remains informal.
Here, to investigate the mathematical relationship between imputation error and
power, we adapt a method developed for evaluating the relationship between genotyp-
ing error and power (Gordon et al., 2002; Kang et al., 2004). Our approach does not
use an r2 statistic, and unlike in the tag-SNP context, in which the inﬂation factor
depends only on the LD between the tag and disease SNPs, the corresponding inﬂa-
tion factor in the imputation context is a function of nine parameters. Consider two
2 × 3 chi-squared tests of association, examining the relationship between the three
possible genotypes of a biallelic marker and case-control status. The ﬁrst test uses
the true genotypes of the marker, whereas the second test uses genotypes measured
with the possibility of imputation error. Suppose that k is the ratio of the number of
controls to the number of cases. Denote by MAFcontrols the frequency of the minor
allele in controls, and by MAFcases the frequency of this same allele in cases. Thus,
0 ≤ MAFcontrols ≤ 1/2 and 0 ≤ MAFcases ≤ 1. We label the minor allele in controls
by A, the major allele in controls by B, genotype AA by 1, AB by 2, and BB by 3.
For i, j ∈ {1, 2, 3}, we let ij be the probability that genotype i is imputed as genotype
j. Because
∑3
j=1 ij = 1 for each i, only six error parameters must be considered: 12,
13, 21, 23, 31, and 32.
Gordon et al. (2002) and Kang et al. (2004) determined the relationship between
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the two 2× 3 chi-squared test statistics at a locus, showing that the test statistic for
association between true genotype and disease in a sample of size N has the same
asymptotic distribution as the test statistic for association between imputed genotype
and disease in a sample of size Nf , where f ≥ 1 is a rational function of 12, 13,
21, 23, 31, 32, k, MAFcases and MAFcontrols that represents the sample size inﬂation
factor. Thus, if a sample of size at least N is required for achieving a speciﬁed level
of power when genotype is measured without error, then a sample of size at least
Nf is required for achieving the same power when genotype is imputed with error.
We use a special case of the formula for f , assuming k = 1, so that a study has
equally many cases and controls; we also assume Hardy-Weinberg proportions are
satisﬁed separately in cases and controls. With these assumptions, the sample size
inﬂation factor due to imputation error can be written f = g/g∗, deﬁning g and g∗ as
in eqs. 1 and A.1 of Kang et al. (2004), and matching our notation to that of Kang
et al. (2004) with the substitutions P01 = MAF
2
cases, P02 = 2MAFcases(1−MAFcases),
P03 = (1−MAFcases)2, P11 = MAF2controls, P12 = 2MAFcontrols(1−MAFcontrols), and
P13 = (1−MAFcontrols)2.
To evaluate the sample size inﬂation factor f at levels of imputation error appro-
priate for typical association studies, we ﬁrst estimated the six error parameters using
genotypes of 426 individuals in 29 diverse populations. Employing reference panels
of phased haplotypes based on ∼2,000,000 SNPs in 210 HapMap Phase II individu-
als together with a worldwide study of ∼500,000 SNPs (Jakobsson et al., 2008), we
imputed individual genotypes at markers that were included in the reference data
but not in the worldwide study. For each population, we repeated the imputations
underlying Figure 7 of Huang et al. (2009a), using the same procedure as was used
by Huang et al. (2009a), to obtain an imputed data set of 513 markers. This set
consisted of probabilistic imputations relying on the subset of reference individuals
that in the work of Huang et al. (2009a) produced the highest imputation accuracy
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for that population, among seven choices. The genotypes of Pemberton et al. (2008),
which update those reported by Conrad et al. (2006), were treated as true genotypes
of the 513 markers for measurement of ij. For each population, at each marker, the
minor and major alleles were determined only using the “true” genotype data from
that population. If each allele had frequency 50%, then the minor allele was assigned
at random.
Treating the 426 individuals as unaﬀected, we classiﬁed 218,345 true genotypes
(426× 513, excluding missing data) by category, and separately for each population,
we estimated 12, 13, 21, 23, 31, and 32. Each true genotype was categorized as
follows: 1—minor allele homozygote; 2—heterozygote; 3—major allele homozygote.
Considering all true genotypes in a population at all 513 markers, denote the number
of true genotypes of types 1, 2, and 3 by n1, n2, and n3, respectively. For each
population, n1, the smallest of the three quantities, was at least 70, so that at least
70 true genotypes were used in estimating each error parameter. For n1, n2, and n3,
the medians across populations were 411, 1967, and 3679, respectively.
To incorporate the uncertainty inherent in imputing a genotype, posterior prob-
abilities of imputing types 1, 2, and 3 were obtained. Considering the ni genotypes
of type i, denote the posterior probability that genotype  was imputed to have
type j by qij. For each i, j ∈ {1, 2, 3}, i = j, we computed ij for the popula-
tion as
∑ni
=1 qij/ni. The “overall imputation error rate,” a weighted average of the
ij that evaluates the total fraction of alleles imputed incorrectly, was calculated as
[(1
2
12 + 13)n1 + (
1
2
21 +
1
2
23)n2 + (31 +
1
2
32)n3]/(n1 + n2 + n3).
For each population, Figure 3.1 displays the estimated values of ij. In most pop-
ulations, the highest imputation error rate is 12, indicating that conditional on true
genotype the highest-probability error is misclassiﬁcation of a minor allele homozy-
gote as a heterozygote. The next highest error rate is usually 13 or 23, reﬂecting
misclassiﬁcation probabilities for minor allele homozygotes or heterozygotes, respec-
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tively, as major allele homozygotes. Misclassiﬁcation probabilities for major allele
homozygotes or heterozygotes as minor allele homozygotes (31, 21) are generally
low.
Treating the estimated values of ij as parametric values, for each population,
we evaluated the sample size inﬂation factor f for various choices of the unknown
MAFcases and MAFcontrols. Because the diﬀerence δ = MAFcases − MAFcontrols can
be viewed as a measure of the magnitude of the association at a disease locus, we
reparametrized f in terms of δ and MAFcontrols. Thus, using observed levels of impu-
tation error, we examined the properties of f across the range of possible frequencies
for the disease allele in cases and controls (Figure 3.2). For most choices of the pa-
rameter values in most populations, the inﬂation factor f lies between 1.1 and 1.6.
For most African populations, consistent with their higher imputation error rates, f
is considerably greater than in other populations, ranging from 1.3 to 2.5 for most
choices of the parameter values. The inﬂation factor is especially high in the San and
Mbuti Pygmy populations, in which nearly all choices examined for δ and MAFcontrols
produce f  1.7. Disease alleles are diﬃcult to detect when |δ| is small, and Figure
3.2 demonstrates that for several populations, the sample size inﬂation factor is great-
est for small |δ|, particularly when the disease locus has a low minor allele frequency
of MAFcontrols = 0.05.
Because the parameters MAFcases and MAFcontrols are unknown in actual asso-
ciation studies, for each population, conditional on the imputation error parameters
ij, we examined the minimal and maximal values of the sample size inﬂation factor
f across the range of possible values for MAFcases and MAFcontrols (Figure 3.3). For
most non-African populations, considering the range of possible values for the minor
allele frequency in controls, the minimal f is typically in the range 1.1-1.2 and the
maximum is typically in the range 1.2-1.6, indicating that the extra sample size re-
quired for maintaining power is usually at least 10-20% and at most 20-60%. The
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maximal f is generally greater for low values of MAFcontrols.
Examining the minimal and maximal sample size inﬂation factor across the range
of disease allele frequencies (Figure 3.3), the values are greatest in populations with
the highest imputation error rates (Figure 3.1). Figure 3.4 quantiﬁes this observation,
illustrating the relationships with overall imputation error rate of the minimal and
maximal values of f . A linear regression of the minimal sample size inﬂation factor on
overall imputation error rate when MAFcontrols is ﬁxed at 0.3, forced through the point
at which no imputation errors occur and therefore no sample size inﬂation occurs,
provides a close ﬁt for most populations, with the exceptions of the San and Mbuti
Pygmy populations. The slope for this regression is 6.911, and the corresponding
regression for the maximal sample size inﬂation factor has a slope of 10.177. Excluding
the San and Mbuti Pygmy populations, the slopes of the regressions for the minimal
and maximal sample size inﬂation factors decrease to 6.203 and 8.836, respectively
(Figure S3.1). More generally, the regression slopes generally lie between 5 and 13
when ﬁxing MAFcontrols at various values across its range, either including or excluding
the San and Mbuti Pygmy populations (Figures S3.1, S3.2). These values have the
interpretation that each 1% increase in overall imputation error rate translates to an
increase of ∼5-13% in the sample size required for maintaining power.
Our results have important implications for imputation studies. In the tag-SNP
setting, for small x, a high LD level of r2 = 1− x produces a relatively small sample
size inﬂation factor of 1/(1−x) ≈ 1+x, so that each 1% loss in the r2 measure of LD
leads to a ∼1% gain in the required sample size. In the imputation setting, however,
imputation accuracy of 1−x produces a typical inﬂation factor of ∼1+5x to ∼1+13x,
so that each 1% loss in imputation accuracy leads to a∼5-13% increase in the required
sample size. As a result, even low levels of imputation error can have sizeable conse-
quences. For example, measures that aim to assess genomic coverage for imputation
methods might need to require stringent levels of imputation error in evaluating the
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proportion of the genome that is suited to imputation-based association mapping.
Studies that aim to conﬁrm associations at imputed markers in populations with
lower imputation accuracy might inherently be disadvantaged for success in replica-
tion studies. In these various settings, careful assessment of appropriate sample sizes
in power calculations will be essential for progress in imputation-based disease-gene
identiﬁcation. One key observation is that imputation error produces the greatest
sample-size inﬂation for markers with low minor allele frequency (MAFcontrols ≤ 0.1),
and for such markers the sample-size inﬂation for each 1% imputation error can be as
high as ∼15-35% (Figures S3.1, S3.2). As GWA eﬀorts begin to focus on the impact of
rare alleles on complex diseases, the potentially serious eﬀects of imputation error for
detecting such alleles will be a central consideration for forthcoming studies. For such
studies, it will be informative to examine values of the imputation error parameters
ij evaluated speciﬁcally from rare alleles.
We note that the linear dependence of the minimal and maximal sample size in-
ﬂation factor on overall imputation error rate, as illustrated in Figure 3.4, is only ap-
proximate. This approximate linear relationship arises because the overall imputation
error rate is a composite parameter dependent on the six underlying ij parameters,
each of which aﬀects the inﬂation factor in an approximately linear manner. Based
on a ﬁrst-order Taylor series expansion for f , for each i and j, Kang et al. (2004)
derived cost functions Cij so that if all error parameters except ij are set to zero and
ij is small, then the sample size inﬂation factor is approximately 1 + Cijij. These
linear approximations accurately reﬂect the sample size inﬂation factor in most pop-
ulations except at the lowest values of MAFcases and MAFcontrols (results not shown),
and suggest that in general, the greatest cost is incurred from errors in imputing
minor allele homozygotes as major allele homozygotes (Figure 3.5). It is noteworthy
that the linear regressions in Figure 3.4 provide the poorest underestimates in the
San population, for which the parameter 13 for the most costly type of error was
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high, and for which the pattern of errors diﬀered somewhat from the corresponding
patterns in the other populations (Figure 3.1).
While an increased sample size provides one approach to maintaining power in
an imputation-based study, an alternative strategy is to instead decrease imputation
error. Reductions in imputation error can be achieved through a combination of al-
gorithmic advances and optimal choices of imputation algorithms (Pei et al., 2008;
Nothnagel et al., 2009), improvements in usage of existing reference panels (Huang
et al., 2009a; Howie et al., 2009), and expanded marker density and sample inclusion
in these panels (Browning & Browning, 2009; Becker et al., 2009). A fourth approach
involves incorporating information on relatives of study subjects to improve phase
estimates at measured markers; although this approach will not eliminate errors ow-
ing to incorrect imputation conditional on correctly estimated phase, it will reduce
imputation errors that arise from incorrect phase estimation.
For populations with relatively little imputation error, in which large samples are
easily obtained, the required sample size increase produced by imputation error might
not pose a signiﬁcant obstacle for GWA studies. In other populations in which subject
recruitment is diﬃcult and the sample size inﬂation required for maintaining power
is extreme, reduction of imputation error might be more feasible than an increase in
sample size. As GWA studies begin diversifying to incorporate additional populations
beyond the populations of European origin that have been typical of most investi-
gations to date (Cooper et al., 2008), it will be important to evaluate the relative
merits of the various approaches for overcoming the consequences of imputation error
to improve the potential of imputation-based association studies.
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Figure 3.1: Genotype misclassiﬁcation rates at imputed loci, in each of 29 popula-
tions. Each bar plot presents a particular error rate ij, where ij represents the
probability that genotype i is imputed as genotype j (1—minor allele homozygote,
2—heterozygote, 3—major allele homozygote). For each population, the greatest of
the six error rates is shown in color, with a color characteristic of the geographic re-
gion of the population. For convenience in interpreting the ﬁgure, the vertical dashed
line indicates 15% error. The values plotted in the ﬁgure appear together with the
overall imputation error rate in Table S3.1.
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Figure 3.2: Sample size inﬂation factor f required for maintaining statistical power at
imputed loci, as a function of the true diﬀerence in the frequency of the minor allele
between cases and controls. Each plot utilizes the estimated imputation error rates in
Figure 3.1 for a speciﬁc population. For each population, the inﬂation factor is plotted
for ﬁve choices of the true minor allele frequency in controls (0.05, 0.15, 0.25, 0.35, and
0.45). Note that MAFcontrols ranges from 0 to 0.5, whereas MAFcases, representing
the frequency in cases of the minor allele in controls, ranges from 0 to 1. We used a
step size of 0.001 for MAFcases and disregarded points with MAFcases = MAFcontrols.
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Figure 3.3: Maximal and minimal sample size inﬂation factor at imputed loci as
functions of the true minor allele frequency in controls, in each of 29 populations.
For each value of MAFcontrols from 0.005 to 0.5 with a step size of 0.005, the value
plotted is the maximal or minimal value of the inﬂation factor f , considering choices
of MAFcases ranging from 0 to 1 with a step size of 0.001 (MAFcases = MAFcontrols).
Graphs for individual populations are color-coded by geographic region. (A) Maximal
sample size inﬂation factor. (B) Minimal sample size inﬂation factor.
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Figure 3.4: Maximal and minimal sample size inﬂation factor as functions of the
overall imputation error rate, for an imputed disease locus with true minor allele
frequency 0.3 in controls. Populations are color-coded by geographic region, and
two data points appear for each population, a maximum and a minimum. Best-ﬁt
linear regression lines for the maxima and minima, forced through the point (0,1),
indicate the increase in the inﬂation factor with increasing imputation error rate. For
example, the lines indicate that in most populations, at MAFcontrols = 0.3, imputation
error rates of 2-6% correspond to sample size inﬂation factors of ∼14-53%, and each
additional increase of 1% in imputation error corresponds to an increase of ∼7-10%
in the inﬂation factor.
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Figure 3.5: Cost coeﬃcients as functions of MAFcases for the ﬁxed value MAFcontrols =
0.3. The coeﬃcient Cij provides an approximation to the relative magnitude of the
sample size inﬂation due to the error parameter ij. Thus, a small increase of x in the
imputation error parameter ij adds approximately Cijx to the sample size inﬂation
factor. The sum of the six cost coeﬃcients, Csum, has the interpretation that Csumx
is added to the sample size inﬂation factor when all six of the ij are simultaneously
set to x. Each of the cost coeﬃcients was evaluated for values of MAFcases from 0.005
to 0.995 at intervals of 0.01.
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Figure S3.1: Maximal and minimal sample size inﬂation factor as functions of the
overall imputation error rate, for an imputed disease locus with true minor allele
frequency ﬁxed in controls, excluding the San and Mbuti Pygmy populations. Each
plot has MAFcontrols ﬁxed at a diﬀerent value. Population symbols are the same as
in Figure 3.4, and two data points appear for each population, a maximum and a
minimum. Best-ﬁt linear regression lines for the maxima and minima, forced through
the point (0,1), indicate the increase in the inﬂation factor with increasing imputation
error rate.
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Figure S3.2: Maximal and minimal sample size inﬂation factor as functions of the
overall imputation error rate, for an imputed disease locus with true minor allele
frequency ﬁxed in controls, considering all 29 populations. Each plot has MAFcontrols
ﬁxed at a diﬀerent value. Population symbols are the same as in Figure 3.4, and two
data points appear for each population, a maximum and a minimum. Best-ﬁt linear
regression lines for the maxima and minima, forced through the point (0,1), indicate
the increase in the inﬂation factor with increasing imputation error rate. The plot
for MAFcontrols = 0.3 also appears in Figure 3.4.
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Table S3.1: Genotype misclassiﬁcation error rates ij in each of 29 populations. Each
column shows a particular error rate ij, where ij represents the probability that
genotype i is imputed as genotype j (1—minor allele homozygote, 2—heterozygote,
3—major allele homozygote). For each population, the greatest of the six error rates
is shown in bold. The values of ij are identical to those plotted in Figure 3.1. The
ﬁnal column represents the overall imputation error rate, a weighted sum of the six
ij with the weights determined by the frequencies of the three categories of genotype.
Population 12 13 21 23 31 32 Overall
imputation
error rate
San 0.236 0.082 0.101 0.180 0.037 0.104 0.109
Mbuti Pygmy 0.159 0.059 0.067 0.161 0.034 0.103 0.096
Biaka Pygmy 0.134 0.038 0.045 0.111 0.026 0.086 0.075
Bantu (Kenya) 0.101 0.035 0.028 0.073 0.021 0.053 0.052
Bantu (S. Africa) 0.108 0.049 0.027 0.066 0.023 0.063 0.055
Yoruba 0.073 0.030 0.021 0.050 0.023 0.034 0.040
Mandenka 0.080 0.025 0.027 0.065 0.022 0.042 0.046
Mozabite 0.073 0.027 0.019 0.045 0.023 0.035 0.039
Bedouin 0.057 0.038 0.020 0.040 0.019 0.028 0.035
Palestinian 0.057 0.033 0.017 0.040 0.020 0.023 0.033
Druze 0.047 0.028 0.014 0.032 0.020 0.024 0.031
Basque 0.034 0.037 0.009 0.022 0.021 0.018 0.027
Russian 0.049 0.027 0.011 0.028 0.018 0.013 0.024
Adygei 0.038 0.022 0.011 0.027 0.021 0.017 0.027
Balochi 0.046 0.036 0.015 0.038 0.020 0.021 0.031
Kalash 0.044 0.036 0.015 0.028 0.021 0.022 0.031
Burusho 0.060 0.032 0.018 0.033 0.021 0.026 0.033
Uygur 0.048 0.021 0.012 0.022 0.024 0.020 0.029
Yakut 0.050 0.034 0.015 0.027 0.025 0.019 0.032
Mongola 0.064 0.025 0.011 0.029 0.023 0.020 0.029
Daur 0.057 0.026 0.011 0.025 0.021 0.020 0.028
Yi 0.057 0.028 0.009 0.023 0.024 0.021 0.029
Cambodian 0.050 0.016 0.013 0.032 0.023 0.019 0.030
Lahu 0.045 0.025 0.013 0.021 0.022 0.017 0.027
Melanesian 0.059 0.030 0.025 0.041 0.024 0.035 0.040
Papuan 0.068 0.037 0.036 0.047 0.025 0.038 0.045
Pima 0.043 0.012 0.011 0.019 0.029 0.017 0.029
Maya 0.032 0.027 0.016 0.027 0.019 0.018 0.027
Colombian 0.054 0.051 0.013 0.031 0.023 0.020 0.032
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CHAPTER IV
Haplotype Variation and Genotype Imputation in
African Populations
4.1 Introduction
Africa has consistently been identiﬁed as the part of the world where the level of
human genetic variation is greatest (e.g., Bowcock et al., 1994; Stephens et al., 2001;
Ramachandran et al., 2005; Tishkoﬀ et al., 2009), and genomic studies have also
conﬁrmed that African populations have the lowest levels of linkage disequilibrium
(LD; Reich et al., 2001; Tishkoﬀ & Kidd, 2004; Conrad et al., 2006; Jakobsson et al.,
2008). The high diversity and the low LD in Africa in turn inﬂuence the design and
analysis of genome-wide association (GWA) studies in African populations (Rosenberg
et al., 2010; Teo et al., 2010).
Recent strategies for ﬁnding causal variants that underlie common diseases have
been based on LD, or the non-random association of variants at separate genetic loci.
Because of shared inheritance of single-nucleotide polymorphism (SNP) variants at
neighboring sites, an association detected between disease status and genotypes at
a marker can indicate the presence of a nearby disease-susceptibility locus. Thus,
highly informative “tag SNPs” that show considerable LD with other SNPs in the
genome have been used as markers for ﬁnding disease associations.
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The general utility of the tag-SNP approach is partly determined by the portability
of tag SNPs, the extent to which tag SNPs chosen based on haplotypic patterns in a
reference population perform in identifying disease genes in study populations whose
patterns of haplotype variation diﬀer from those of reference populations. Tag-SNP
portability has been shown to be aﬀected primarily by the level of LD in the study
population, with genetic similarity of the reference and study populations playing
a less critical but still important role (Conrad et al., 2006). Thus, for populations
that have relatively low levels of LD and that are genetically diﬀerent from standard
reference groups—a class of populations that includes much of Sub-Saharan Africa—
the tag-SNP approach is less eﬀective than for other populations.
Improved designs for GWA studies have recently used LD patterns to impute ge-
netic variants that have not been genotyped in the study sample but that have been
genotyped in a reference panel. Imputation of unknown variants, followed by test-
ing of these variants for disease association, has been shown to improve the genomic
coverage and statistical power of GWA studies (e.g., Marchini et al., 2007; Servin
& Stephens, 2007; Li et al., 2009). Investigations of genotype imputation in world-
wide populations, however, suggest that imputation accuracy is low in most African
populations, again owing largely to low levels of LD and high levels of genetic diver-
sity (Huang et al., 2009a; Teo et al., 2010). This diﬀerence in imputation accuracy
in turn can substantially inﬂate the sample size required for maintaining power in
imputation-based GWA studies in African populations (Huang et al., 2009b).
Despite the reduced tag-SNP portability and imputation accuracy in African pop-
ulations, data on patterns of haplotype variation in Africa and their applications to
the design of GWA studies are relatively scarce. In this study, we extend the char-
acterization of African haplotype diversity and LD to a total of 15 Sub-Saharan
African populations, and we perform an investigation of imputation in African popu-
lations. The combination of high levels of genetic variation, low levels of LD, and large
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numbers of private haplotypes in African populations makes imputation of untyped
markers particularly challenging in Africans. We examine a variety of imputation
designs in African populations, and by considering summary statistics on patterns of
haplotype variation, we demonstrate a close relationship between maximal imputa-
tion accuracy and statistics that measure diﬀerent forms of genetic similarity between
samples from a target African population and those available in reference panels.
4.2 Results
4.2.1 Data
We considered a dataset of 1,107 individuals from 63 populations worldwide, in-
cluding 15 Sub-Saharan African populations. Each individual was genotyped for 2,810
SNPs spread across 36 genomic regions, 16 on chromosome 21, 16 on other autosomes,
and four on the non-pseudoautosomal part of the X chromosome. Each region was
designed to contain a core of 60 SNPs genotyped at high density, with 12 SNPs at
lower density extending in each direction away from the core. This set of genomic
regions was originally chosen to represent the range of recombination rates and gene
densities present in the human genome, and most SNPs were chosen among those
discovered in multiethnic panels (Conrad et al., 2006). The dataset subsumes the
dataset of Pemberton et al. (2008) on 957 individuals from 55 populations (see Ma-
terials and Methods), and the 150 newly genotyped individuals (Table 4.1) represent
eight Sub-Saharan African populations chosen to provide a geographically and genet-
ically diverse subset among the samples of Tishkoﬀ et al. (2009). Our investigations
focus primarily on the 15 Sub-Saharan African populations.
For some analyses of imputation in study populations on the basis of external
reference panels, the 1,107 individuals were augmented with genotypes in 901 un-
related individuals from 11 populations in release 2 of Phase 3 of the International
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Haplotype Map Project (2010), representing a subset of the collection of 1,117 un-
related individuals in HapMap Phase 3 release 3 that was described by Pemberton
et al. (2010). In these HapMap individuals, 517 markers were considered, all of which
were located on chromosome 21 and were typed in both the 63 study populations
and the 11 HapMap populations. The HapMap Phase 3 data contain four groups
with signiﬁcant recent African ancestry: ASW (African Americans from the south-
west of the USA), LWK (Luhya from Webuye, Kenya), MKK (Maasai from Kinyawa,
Kenya), and YRI (Yoruba from Ibadan, Nigeria). From the four HapMap groups, we
constructed all 24−1 = 15 possible mixtures of one or more among these four groups.
We then considered each of these panels as reference data for imputation in the 15
Sub-Saharan African target populations.
4.2.2 Haplotype Variation
We assessed several aspects of haplotype variation, including “haplotype ﬂow,”
private haplotypes, LD, and haplotype sharing between sampled populations and
HapMap reference populations. These various computations are used later in ex-
plaining the outcomes of genotype-imputation experiments.
Haplotype ﬂow. Using the sample-size-corrected z-statistic of Conrad et al.
(2006), we computed pairwise haplotype sharing between major geographic regions—
Sub-Saharan Africa, the Middle East (and North Africa), Europe, Central/South
Asia, Oceania, and the Americas. For a ﬁxed haplotype length, this statistic mea-
sures the fraction of haplotypes in a sample of speciﬁed size from one population that
are also found in a second population. It can be viewed either as a measure of “out-
ward haplotype ﬂow” for the second population, quantifying the extent to which this
population could have contributed haplotypes to the ﬁrst population, or alternatively,
as a measure of “inward haplotype ﬂow” for the ﬁrst population.
As was observed by Conrad et al. (2006), the outward haplotype ﬂow from Sub-
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Saharan Africa (henceforth sometimes abbreviated to “Africa”) to each of the other
regions exceeds the corresponding inward haplotype ﬂow (Figure 4.1). Haplotype
sharing between regions is lower when comparing Africa to other regions than when
comparing most pairs of non-African regions (Figure 4.1). Consistently across hap-
lotype lengths, haplotype sharing between Africa and other regions is greater when
the full set of 15 African populations is used than when using the seven previously
sampled African populations alone. It is possible that the newly sampled popula-
tions, most of which were sampled in East Africa, represent the groups that migrated
out of Africa more closely than do the previously sampled groups, thereby producing
increased haplotype sharing with non-Africans. Indeed, some of these populations, in-
cluding Beja, Borana, and Fulani have been observed to partially cluster with Middle
Eastern populations in analyses of population structure (Tishkoﬀ et al., 2009).
Private haplotypes. For each geographic region, we computed the number of
private haplotypes found only in that region. Our computations used a rarefaction
approach (Kalinowski, 2004; Conrad et al., 2006) to adjust for diﬀerences in sample
sizes across regions. We observe much larger numbers of private haplotypes in Africa
than in non-African regions (Figure 4.2A), consistent with greater levels of diversity
and lower LD in Africa. For example, in a sample of 54 chromosomes, for haplotypes
of length 25kb, we ﬁnd on average 7.35 private haplotypes in Africa, whereas we
only ﬁnd on average 1.71 private haplotypes in the Middle East, and even fewer
in the other regions (Figure 4.2A). Within Africa, the greatest numbers of private
haplotypes are found in hunter-gatherer populations, such as the San, Biaka Pygmy,
and Mbuti Pygmy groups (Figure 4.2B). These three populations do not stand out
in other aspects of diversity, however, as they do not have particularly large numbers
of distinct haplotypes (Figure S4.1) or high haplotype heterozygosity (Figure S4.2).
Linkage disequilibrium. LD, as measured by mean r2 values for SNP pairs in
physical distance bins, declines with increasing physical distance between SNPs for
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all 63 populations (Figure 4.3). African populations have the lowest levels of LD, fol-
lowed by populations from the Middle East, Central/South Asia, Europe, East Asia,
Oceania, and the Americas. For example, for SNPs with minor allele frequency 0.05
or greater, mean r2 across African populations, when calculated for all SNP pairs in
bins of width 6kb, drops below 0.4 at a distance of 2.5kb. The corresponding dis-
tances at which mean r2 ﬁrst drops below 0.4 are 5.2kb, 7.1kb, 9.6kb, 10.5kb, 19.2kb,
and 33.3kb for the populations of the Middle East, Central/South Asia, Europe, East
Asia, Oceania, and the Americas, respectively. Thus, in considering a larger sample
of Sub-Saharan African populations than in most previous studies, we continue to
ﬁnd comparatively low LD in African populations.
Haplotype sharing with the HapMap. Using a statistic φ that measures
the extent to which the common haplotypes in one population are also common
in a second population, Conrad et al. (2006) found that the HapMap Phase 2 data
capture common haplotypes relatively well in most groups, with the primary exception
of African populations. Employing this same statistic, an expanded dataset with
additional African populations, and the newer HapMap Phase 3 data, we continue to
observe that for African populations, levels of sharing for common 50kb haplotypes
(>10% frequency) with HapMap Phase 3 are signiﬁcantly lower than corresponding
levels of sharing with HapMap Phase 3 for non-African populations (P < 0.0001,
one-sided Wilcoxon rank-sum test).
Figure 4.4 shows the fraction of common haplotypes in individual populations that
are also common in the HapMap Phase 3 populations, demonstrating that the most
similar HapMap group for a population is generally found in the same or the closest
geographic region. Although common haplotypes of several African populations (San,
Mbuti Pygmy, and Biaka Pygmy) continue to have the greatest diﬀerence from those
of the individual HapMap populations, similarly to the observation of Conrad et al.
(2006), they can generally be better captured by pooled collections consisting of two
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or more HapMap Phase 3 populations than by the HapMap populations individually
(Figure 4.5). In particular, testing the diﬀerence in haplotype sharing for common
50kb haplotypes in African populations with the combination panels that achieve
the maximal haplotype sharing (among the 15 combinations of one or more HapMap
Phase 3 populations of African descent) and with the HapMap Phase 3 YRI panel,
sharing is signiﬁcantly greater with the combination panels than with the YRI panel
alone (P < 0.0001, one-sided Wilcoxon signed-rank test).
4.2.3 Genotype Imputation
To understand the properties of genotype imputation in African populations, we
considered two designs, both using the software MACH (Li et al., 2006, 2010). We
ﬁrst examined imputation accuracy for all pairs among the 63 populations, with one
population chosen as the reference and another as the target. We next identiﬁed,
for each of the 15 African populations, the optimal reference panel chosen from the
HapMap.
Imputation at untyped markers based on population samples. To exam-
ine the variation in imputation accuracy across potential reference populations, for
each of 63 × 63 population pairs consisting of a target population and a reference
population, we imputed missing genotypes at randomly selected hidden markers in
the target population on the basis of a small panel of individuals in the reference
population, holding reference panel size constant at six individuals. The panel size of
six individuals corresponds to the smallest sample size among all 63 populations, and
therefore, it represents the largest panel size that permits comparable evaluations of
all pairs of distinct populations.
Considering all 63× 63 imputations, we ﬁnd that except for African target popu-
lations, imputing missing genotypes in a target population on the basis of a reference
population from the same geographic region yields higher imputation accuracy than
75
the mean of all values in the 63 × 63 matrix of imputation accuracies (Figure 4.6).
By contrast, imputing missing genotypes in African target groups using non-African
reference groups yields imputation accuracy lower than the mean, except in a few
target populations (e.g., Beja, Iraqw, and Sandawe with the Mozabite group as ref-
erence). Among all 779 pairs consisting of reference and target populations from the
same geographic region, we ﬁnd that 30.4% of the imputations appear in the top
10% of all 63× 63 imputation accuracies, with values ranging from 88.2% to 94.6%.
On the other hand, among 720 pairs consisting of an African target population and
a non-African reference population, 36.7% appear in the bottom 10% of imputation
accuracies, with values ranging between 59.3% and 78.2%.
In this imputation experiment, we observe an asymmetry of imputation perfor-
mance in population pairs consisting of a reference population and a target population
with diﬀerent geographic origins. That is, in many cases, imputation using one popu-
lation as a reference panel and a second population from a diﬀerent geographic region
as a target has considerably higher or lower accuracy than in a scenario with the roles
of the populations reversed. This reference-target asymmetry is most pronounced in
population pairs in which one population is African and the other is non-African; in
628 or 87.2% of 720 such pairs (15 African × 48 non-African populations), imputation
accuracy is lower when imputing untyped markers in an African population on the
basis of a non-African population than when performing imputation in the reverse
direction. For population pairs of non-African descent from diﬀerent geographic re-
gions, we observe a similar reference-target asymmetry. For instance, in 113 or 78.5%
of 144 pairs containing a European and an East Asian population (8 European × 18
East Asian populations), imputation accuracy is lower in the European population
than in the East Asian population on the basis of the other population as reference
data.
Evaluating the portability of a reference population for imputation in target popu-
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lations other than the reference population itself, we consider two metrics—the num-
ber of target populations in which a reference population serves as either the best or
second-best reference panel, and the mean imputation accuracy across target popula-
tions in which imputation is performed using the reference population. Using the ﬁrst
metric to identify top-performing reference groups across the range of possible target
populations, we ﬁnd Sengwer and Yoruba to be the most portable reference groups
for imputation in African populations. Sengwer is the best or second-best reference
group in six of the 14 other African samples, and Yoruba is the best or second-best
panel in ﬁve of 14. Additionally, Sengwer and Yoruba produce the highest mean
imputation accuracy across the 14 remaining African populations (86.0% and 85.8%,
respectively).
Imputation at untyped markers based on the HapMap. To identify suit-
able HapMap reference panels for imputation in the 15 African populations, in each
population, we masked a ﬁxed set of randomly selected markers and then imputed
missing genotypes at these markers on the basis of each of the 15 possible combina-
tions of the four HapMap panels of African descent.
For each African target population, Figure 4.7 reports the optimal reference panel
chosen from the 15 combinations of HapMap reference groups. All except one of
the African populations are most accurately imputed using a reference panel that
contains individuals from new HapMap Phase 3 samples of African ancestry (ASW,
LWK, and MKK). The only exception is Mandenka, for which the optimal reference
panel consists solely of the HapMap YRI population. The combined panel of all four
HapMap populations of African origin is not the optimal reference group in any of the
15 African populations, and it is the second-best reference panel in only three of the 15
African groups (Kenyan Bantus, Fulani and Mada). Interestingly, several populations
(Beja, Biaka Pygmy, Borana, Fulani, Mbuti Pygmy, and Sandawe) have in their
optimal reference panels the HapMap ASW admixed sample of African Americans.
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On the basis of reference panels consisting of mixtures of the HapMap Phase 3
populations, the San, Mbuti Pygmy, and Biaka Pygmy populations continue to be
the most poorly imputed groups, as was previously observed with earlier reference
panels from HapMap Phase 2 (Huang et al., 2009a). Yoruba remains the best-imputed
population, with the combination of the HapMap LWK and YRI populations as its
optimal reference panel. Although the size of the underlying optimal reference panels
varies widely across the 15 target populations, from 80 individuals for the LWK panel
to 284 individuals for the combined panel containing the HapMap LWK, MKK, and
YRI populations, maximal imputation accuracy varies only moderately across the 15
African target populations. The highest and lowest values diﬀer by less than 7.0%
among all 15 populations, and by less than 2.0% for the 11 populations with highest
maximal imputation accuracy.
To evaluate the improvement in imputation accuracy in African populations re-
sulting from the addition of the ASW, LWK, and MKK samples to the HapMap
Phase 3 data, for each African population, we computed the diﬀerence between the
maximal imputation accuracy in the population using its optimal combination of ref-
erence panels and the imputation accuracy in the population on the basis of the YRI
reference panel. Averaged across African populations, the increase in imputation ac-
curacy is 1.3%, corresponding to a mean percentage reduction of 11.1% in imputation
error rates. Note, additionally, that the HapMap Phase 3 YRI panel examined in our
study contains 80% more unrelated individuals compared to the HapMap Phase 2
YRI panel (from 60 to 108 unrelated individuals); this panel is thus likely to produce
higher imputation accuracy than the earlier panel. Consequently, as a measure of
the improvement in African imputation accuracy on the basis of HapMap Phase 3
compared to HapMap Phase 2, our estimate is likely to be conservative.
To further quantify contributions of individual HapMap Phase 3 panels of African
ancestry to imputation accuracy in the 15 African populations, for each HapMap
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panel of African origin, we computed the diﬀerence in maximal imputation accuracy
attainable in each of the 15 populations using two optimal reference panels, one
chosen from a full collection of combination panels and the other chosen from a
reduced collection. The full collection consisted of all 24 − 1 = 15 combinations
of the four HapMap Phase 3 panels, producing the maximal imputation accuracies
shown in Figure 4.7. The reduced collection, a subset of the full collection, consisted
of 23 − 1 = 7 combinations of the same panels of African descent, excluding the
panel whose contributions were under evaluation. A larger diﬀerence in maximal
imputation accuracy, examining the full and reduced collections, suggests a greater
impact of the HapMap panel under consideration, because of a greater diﬀerence in
imputation accuracy achieved with and without the panel. For each of the 15 African
populations, we ranked the four HapMap Phase 3 panels of African origin by the
diﬀerence in maximal imputation accuracy, ﬁnding that the HapMap ASW panel has
the greatest inﬂuence on maximal imputation accuracy only in Fulani, a group that
has been suggested to have had recent gene ﬂow both with Sub-Saharan African and
with Eurasian populations (Scheinfeldt et al., 2010). Considering the remaining 14
African populations, exclusions of the HapMap MKK, LWK, and YRI panels produce
the greatest impact in six, ﬁve and three populations, respectively. Among the target
populations whose imputation accuracies are most strongly inﬂuenced by a particular
panel, the mean percentage reductions in imputation error rates are 4.1%, 10.4% and
8.3% for MKK, LWK and YRI, respectively (the percentage reduction in imputation
error in Fulani when including the ASW reference panel is 3.8%).
Relating imputation to haplotype variation. The selection of optimal ref-
erence panels for imputation in target populations generally requires an investigator
either to have prior knowledge of the performance of candidate panels in the target
populations or to perform imputation experiments similar to the ones described in the
preceding two sections. However, prior knowledge might be unavailable for unusual
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target populations, and imputation experiments can be computationally intensive.
Thus, for target populations that have not been the focus of previous imputation
studies, the ability to predict the optimal reference panel among a collection of can-
didate panels on the basis of simple genotypic and haplotypic variation statistics
computed for the target and each of its candidate reference groups, can serve as a
computationally attractive approach to the selection of reference panels.
To provide a basis for predicting properties of imputation from statistics on vari-
ation patterns, we examined the dependence of imputation-accuracy results (Fig-
ure 4.7) on our analysis of haplotype variation in the 15 African populations. Both
imputation accuracy and haplotype variation were investigated using the same set of
517 markers that overlapped between our study populations and the HapMap Phase
3 populations. We considered three haplotype-variation statistics from the Haplo-
type Variation section (haplotype sharing for a target population with a reference
population, number of private haplotypes in the target population, and level of LD
in the target population), as well as Fst between target and reference populations,
as possible predictors of imputation accuracy in a target population on the basis of
a reference population. Haplotype sharing and Fst are reasonable predictors because
they provide measures of genetic similarity and distance between a target group and
a reference group. The number of private haplotypes provides a measure of the dis-
tinctiveness of a target population and thus might be expected to be inversely related
to imputation accuracy. Lastly, the level of LD as measured by r2 is a reasonable
predictor because the strength of correlation among nearby SNPs on a target hap-
lotype underlies our ability to impute genotypes at an untyped SNP using genotype
information at a nearby typed SNP.
For the 15 African target populations, with missing genotypes imputed based on
their respective optimal HapMap mixtures, Figure 4.8 displays the relationships of
imputation accuracy with four summary statistics—the number of private haplotypes
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of length 50kb, the level of LD at 50kb, the haplotype sharing for target populations
with their optimal reference groups using a window size of 50kb, and Fst between
the target and reference populations. Haplotype sharing for a target population with
a reference population, as well as Fst between a target population and a reference
population, each produce a strong relationship with imputation accuracy in the target
(with Pearson correlation coeﬃcient r = 0.79 and P = 0.0004 between imputation
accuracy and haplotype sharing, and r = −0.86 and P < 0.0001 between imputation
accuracy and Fst). The relationship between imputation accuracy and the number of
private haplotypes is weaker (r = −0.66, P = 0.0070), and the relationship between
imputation accuracy and the level of LD is not statistically signiﬁcant (r = 0.15, P =
0.6044).
Statistics on genetic similarity between an African target population and a HapMap
reference group can in some cases be used for identifying the optimal reference panel
for imputation in the target. Each plot in Figure 4.9 shows the imputation accu-
racies in a given target population on the basis of each of the 15 HapMap mixture
panels, sorted on the x-axis according to the haplotype-sharing statistic. In four of
15 target populations, the optimal HapMap mixture, as shown in Figure 4.7, is in-
deed the mixture with the highest haplotype sharing; in most target populations,
use of the mixture with the highest haplotype sharing leads to a relatively small
decrease in imputation accuracy compared to use of the optimal mixture. For each
target population, we computed the diﬀerence in accuracy between the imputation
performed using the mixture with the highest value of the haplotype-sharing statistic
and the imputation performed using the optimal HapMap mixture. The mean loss of
imputation accuracy across the 15 African target populations in this case is 0.0038,
corresponding to a mean percentage increase of 4.2% in imputation error.
Similarly, each plot in Figure 4.10 shows the imputation accuracies in a target pop-
ulation on the basis of the 15 HapMap mixture panels, sorted instead on the x-axis
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according to Fst. The optimal HapMap mixture is the mixture with the lowest Fst in
only 3 of 15 target populations. However, in many of the remaining target popula-
tions, the imputation accuracy obtained using the mixture with the lowest Fst is only
very slightly lower than the imputation accuracy obtained using the optimal mixture.
The mean loss in imputation accuracy from use of the lowest-Fst mixture rather than
the optimal mixture is 0.0013, corresponding to a mean percentage increase of 1.3% in
imputation error. This small diﬀerence in imputation accuracy suggests that genetic
similarity between target and reference populations plays a central role in predicting
imputation accuracy in the target population, and that similarity statistics can be
used to guide the selection of suitable reference populations.
4.3 Discussion
Genotype imputation has played an increasingly important role in the analysis
of human genetic variation and genotype-phenotype association, and the continu-
ing growth of genomic resources facilitates the expansion of imputation studies into
new populations. We have found that the availability of additional HapMap Phase
3 populations of African descent increases the accuracy of genotype imputation in
Sub-Saharan African populations, improving the prospects for GWA studies in these
groups. Focusing on populations from Sub-Saharan Africa, we have presented a
detailed investigation of haplotype diversity and genotype imputation, recommend-
ing the use of haplotype-sharing measures and Fst between a target population and
candidate reference populations as guiding criteria for selecting reference panels for
imputation in the target population.
We characterized the level of genetic similarity between populations by the mag-
nitude of their haplotype sharing. Examining the patterns of haplotype sharing at a
regional level, we conﬁrmed earlier observations of asymmetry between African and
non-African populations in haplotype sharing, as reﬂected in the greater “outward”
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than “inward” haplotype ﬂow from Africa to other geographic regions (Conrad et al.,
2006). This asymmetry in haplotype sharing (Figure 4.1) provides a partial explana-
tion for a corresponding reference-target asymmetry in imputation performance for
Africans and non-Africans (Figure 4.6). In particular, the net outward haplotype
ﬂow from Africa to other geographic regions implies that for a non-African haplotype
targeted for imputation on the basis of an African reference population, the probabil-
ity of ﬁnding the same haplotype inherited by descent in the reference population is
greater than the probability of ﬁnding an African haplotype targeted for imputation
in a non-African reference population. An increased probability of ﬁnding reference
chromosomal stretches inherited by descent for a non-African target haplotype in
turn produces an increased probability of correctly inferring missing genotypes of
the non-African target on the basis of African reference haplotypes, compared to the
probability of correctly inferring missing genotypes of an African target on the basis
of non-African reference haplotypes. Following the same argument, we can attribute
much of the asymmetry in imputation performance between collections of popula-
tions from diﬀerent geographic regions to the asymmetry in haplotype sharing for the
populations involved.
The accuracy with which genotypes can be imputed in a target population, though
positively correlated with haplotype sharing and the Fst statistic with the reference
panel, is clearly not solely determined by either of these measures of genetic sim-
ilarity between target and reference populations. For example, considering the 15
African populations, the Mandenka population had the highest maximal haplotype-
sharing fraction across the 15 possible mixtures of the HapMap Phase 3 populations
of African descent (Figure 4.5). Among the 15 African target populations, however,
the Mandenka population had less than the median maximal imputation accuracy on
the basis of the optimal reference panel chosen among the 15 HapMap mixtures. Fu-
ture theoretical work will be important for clarifying the determinants of imputation
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accuracy; in the absence of such work, further investigation of empirical approaches,
some inspired by population-genetic theory, can continue to provide improvements to
imputation in novel target populations (e.g., Egyud et al., 2009; Huang et al., 2009a;
Li et al., 2010; Pas¸aniuc et al., 2010; Shriner et al., 2010).
Although our dataset in 63 worldwide populations enables us to investigate fac-
tors aﬀecting accuracy of genotype imputation in diverse populations, especially in
Sub-Saharan Africans, the relatively small numbers of markers and sample sizes do
limit the scope of our study. For example, because of the small size of the marker set,
the fraction of the markers that we chose to impute in our experiments was less than
that typically used in GWA applications, for which larger fractions of the dataset are
imputed rather than genotyped. This small size of the marker set had the additional
consequence that in our imputation experiment involving the HapMap, for each of
the 15 African target populations, imputation accuracies resulting from use of the top
choices of reference panels did not diﬀer substantially, thereby limiting our ability to
provide clear support for particular mixtures of HapMap panels (Figure 4.7). Further,
for our 63× 63 imputation experiment involving only data from the 63 populations,
we relied on phased haplotypes, and relatively small sample sizes might have lim-
ited phasing accuracy; because phasing accuracy is lowest in populations with lower
LD (Conrad et al., 2006), phasing errors could have contributed to the elevated im-
putation error rates in African target populations (Figure 4.6). We also note that
while the MACH software that we used is among the most commonly used imputa-
tion programs, other methods such as BEAGLE (Browning & Browning, 2007, 2009)
and IMPUTE (Marchini et al., 2007; Howie et al., 2009) are frequently employed.
While the numerical results of the imputation experiments would likely vary with our
methodological choices, however, our primary goal has been to examine the way in
which imputation accuracies relate to each other across diﬀerent reference and target
populations, with a focus on Sub-Saharan Africa, and we do not expect that these
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general patterns would be substantially aﬀected by changes to the imputation soft-
ware, marker sets, or sample sizes. The limitations of our imputation experiments will
become easier to address as large-scale African population-genetic datasets prolifer-
ate, from such sources as genomic studies of human evolution (e.g., Bryc et al., 2010;
Henn et al., 2011) and GWA studies in African and African-American populations
(e.g., Adeyemo et al., 2009; Jallow et al., 2009; Teo et al., 2010).
4.4 Materials and Methods
4.4.1 Data
SNP data. We supplemented the worldwide set of 957 individuals studied by
Pemberton et al. (2008), which itself updated the dataset of Conrad et al. (2006) on
927 individuals from 53 populations, with data on eight additional African popula-
tions. Among 160 African individuals genotyped initially, four were discarded as a
result of poor genotyping quality. For each pair among the remaining 156 individuals,
the fractions of SNPs at which the pair shared 0, 1, and 2 identical alleles were cal-
culated. The computation used all SNPs at which genotyping was attempted, and it
identiﬁed two pairs of duplicate samples and ﬁve pairs of close relatives, two of which
shared one individual. This shared individual was removed from both pairs, and from
each of the ﬁve remaining pairs, the individual with the greater amount of missing
data was removed. Research and ethics approvals and permits were secured prior
to sample collection, as detailed by Tishkoﬀ et al. (2009). Written informed consent
was obtained on-site from all participants, and the institutional review boards of the
University of Maryland at College Park and the University of Pennsylvania approved
the study.
Genotyping was attempted for the African individuals at 3,024 SNPs spread across
36 genomic regions, simultaneously with genotyping of the 30 Indian samples that
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formed the focus of the work of Pemberton et al. (2008). The preparation of the
ﬁnal dataset for this study appears in Pemberton et al. (2008), who incorporated the
African samples in producing a ﬁnal dataset of 2,810 SNPs, but then omitted these
samples in data analysis. Our ﬁnal dataset, considering all 1,107 individuals and 2,810
SNPs, has a missing data rate of 0.11% (0.38% in the 150 newly sampled African
individuals). Of the 2,810 SNPs, a subset of 1,272 SNPs are located on chromosome
21. To investigate genotype imputation in our study samples, we focused on this
subset, which has a missing data rate of 0.10% (0.36% in the 150 newly sampled
African individuals). Haplotype phasing utilized fastPHASE 1.0 (Scheet & Stephens,
2006), following the same approach as in Conrad et al. (2006), and it was completed
by Pemberton et al. (2008).
HapMap data. For some analyses, we incorporated additional reference in-
dividuals for genotype imputation. The reference data consisted of 901 unrelated
individuals in release 2 of HapMap Phase 3 (2010). We used a dataset in which
phased genotypes in these individuals were available at 1,361,534 autosomal SNPs.
Of these SNPs, 18,943 were on chromosome 21, among which 517 were also available
in the 1,107 study individuals. For imputation designs involving HapMap individu-
als as reference data, we assessed imputation accuracy at a subset of the 517 SNPs
by using the unphased genotypes at the 1,272 SNPs from the study sample and the
phased genotypes at the 18,943 chromosome-21 SNPs in the HapMap Phase 3 data.
For imputations that instead used populations in the study sample as reference data,
we evaluated imputation accuracy at a subset of the 1,272 SNPs, using unphased
data for target samples and phased data for reference samples at those SNPs.
4.4.2 Statistical Analyses of Haplotype Variation
Haplotype windows. We computed haplotype summary statistics using haplo-
types deﬁned by “core” SNPs in genomic windows of size w base pairs. In the set
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of SNPs genotyped, core SNPs are SNPs that lie within a more densely genotyped
region with a mean spacing of ∼1.5kb between consecutive SNPs (non-core SNPs lie
in the ﬂanking regions of each core, with a mean spacing of ∼10kb). For each SNP in
a “core” region, a haplotype locus is speciﬁed by the set of allelic states at all SNPs
located in the half-open window [a, a+ w), where a denotes the position of the SNP
under consideration and a + w denotes the position along the chromosome w base
pairs away from the position a. All SNPs deﬁning a haplotype locus are required to
lie completely within a core region. Furthermore, identical haplotypes must have the
same variants for all SNPs with positions in [a, a+w). For each value of the window
size w, we present summary statistics averaged across all haplotype loci of size w.
For instance, for a given population, haplotype heterozygosity was computed for each
haplotype locus and was then averaged across haplotype loci.
Unless otherwise noted, summary statistics on haplotype variation were calculated
twice in our study. We ﬁrst computed the statistics using all 1,800 core SNPs outside
X-chromosomal regions (numbered 23-26 in Table SM.2 of Conrad et al., 2006) for
the characterization of haplotype variation in the study populations (Figs. 4.1-4.3).
The collection of 1,800 SNPs was identical to that used by Pemberton et al. (2008).
For the investigation of the relationship between haplotype variation and imputation
performance (Figs. 4.4, 4.5, and 4.8), we repeated the computation using the set
of 517 SNPs that overlapped between the study samples and the HapMap Phase 3
data so that results on haplotype variation and on imputation accuracy used the
same underlying set of SNPs. Lastly, we computed pairwise Fst between each of 15
African target populations and each of 15 mixtures of HapMap Phase 3 panels of
African ancestry, using the set of 517 SNPs and eq. 5.3 of Weir (1996). All haplotype
summary statistics, as well as Fst, were computed using phased datasets.
Numbers of distinct haplotypes and private haplotypes. To adjust for
sample-size diﬀerences across populations and geographic regions, following Conrad
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et al. (2006), we used a rarefaction approach for estimating the numbers of distinct
haplotypes and private haplotypes. For each of these two statistics, in a sample of
size N , this approach chooses a value g ≤ N and it obtains the statistic by averaging
the expected value of the statistic across all possible subsamples of size g from the
original sample of size N . This method enables a correction for diﬀering sample
sizes across populations, as the same value of the subsample size g can be used in
evaluating a statistic in each population. For all population-level computations of
the two statistics, we used g = 12, which corresponds to the smallest sample size
among 63 populations. For all computations involving geographic regions, we used
g = 54, as the smallest sample size among the seven geographic regions equaled 54
chromosomes.
Haplotype sharing. To compute the fraction of distinct haplotypes shared be-
tween two populations, j and j′, we used the z-statistic of Conrad et al. (2006). For
each haplotype locus, we ﬁrst computed the numbers of distinct haplotypes and the
numbers of private haplotypes for each of the two populations, where private haplo-
types for population j refer to those not found in population j′. This computation
used rarefaction with g = 54 when comparing geographic regions and g = 12 when
comparing populations.
The expected number of distinct haplotypes found in a sample of size g from
population j that will also be found in a sample of size g from population j′ is
then equal to the diﬀerence between the expected number of distinct haplotypes
in population j and the expected number of private haplotypes in population j.
Thus, the z-statistic of Conrad et al. (2006) is an estimator of the fraction of distinct
haplotypes observed in a sample of size g from population j that will also be observed
in a sample of size g from population j′.
Linkage disequilibrium. We measured LD by the correlation coeﬃcient, r2,
between all pairs of SNPs with minor allele frequency greater than some cutoﬀ value,
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c, where c ∈ [0, 1). For each population, we computed the mean r2 and the mean
distance between pairs of SNPs for all SNP pairs within bins of size b; a bin centered
on distance x contains all pairs of distinct SNPs in the interval (x− b/2, x+ b/2]. We
tested the sensitivity of r2 values to various choices of c (0, 0.05, and 0.1) and b (1
kb, 3 kb, 6 kb, and 10 kb), and we found that the choices of c and b had relatively
little eﬀect on the observed LD patterns.
Haplotype sharing with the HapMap. Using the φ statistic (Conrad et al.,
2006), for each population, we computed the fraction of haplotypes common in a
population that were also common in each of the 11 HapMap Phase 3 populations
and in the 15 combinations of one or more HapMap Phase 3 groups of African descent.
This statistic evaluates the number of distinct haplotypes that are common in each
of a pair of populations, as a fraction of the number of distinct haplotypes common
in the population from the pair designated as the “donor.” We used g = 12 in
rarefaction-based evaluations of the number of distinct haplotypes, and the set of 517
SNPs that overlapped with the HapMap Phase 3 data was used for computations of
φ. Estimates of φ were generally insensitive to the choice of cutoﬀ used for deﬁning
“common” haplotypes (haplotype frequency >0.01, >0.05, or >0.1). The φ statistic
was obtained by averaging across haplotype loci within each of the genomic core
regions, and it was then averaged across genomic regions.
4.4.3 Genotype-imputation Experiments
Imputation at untyped markers based on population samples. We ex-
amined how well missing genotypes in each population can be imputed using other
population samples as reference panels. For each population in which imputation was
performed, we masked the same set of 77 SNPs on chromosome 21, randomly cho-
sen among the 517 markers that overlapped between our samples and the HapMap
Phase 3 populations. We then estimated genotypes at these markers using the soft-
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ware MACH (Li et al., 2006, 2010). MACH settings were identical to those used
in imputations of untyped markers in Huang et al. (2009a) except that we dropped
two options, interimInterval, which outputs intermediate results, and mask, which
masks a speciﬁed proportion of genotypes (as opposed to masking the genotypes of
speciﬁc markers in all individuals). For improved genotype estimates, we also in-
creased rounds, the number of rounds for the Markov sampler, from 20 to 50. The
median minor allele frequency of the 77 hidden SNPs ranges from 0.1957 to 0.2895
across the 15 African populations, and from 0.1875 to 0.3036 across 61 populations
(the median minor allele frequency is lower in the Surui and Pima populations).
In each target population, imputation was performed 62 times, each time based
on a subset of the unmasked, phased data from one of the remaining populations as
a reference group. The target data of a population consisted of unphased genotype
data in all individuals available from that population. For all target populations, we
used the same reference data, consisting of haplotypes of six individuals randomly
selected from a reference population.
Additionally, we imputed each population on the basis of itself. For each pop-
ulation, we split its data into two non-overlapping sets and used one set to impute
the other. For 61 of 63 groups, we used the same reference sets of six individuals
described above. For two population samples of size six individuals (San and Tus-
can), we randomly selected ﬁve instead of six individuals and created the reference
set using the unmasked, phased genotype data of these individuals. We then used
unphased genotype data for individuals not sampled for inclusion in the reference set
to form the target set for the evaluation of imputation accuracy. Thus, for imputation
in a target population with sample size n using reference data from the same popu-
lation, for 61 populations, the target set consisted of n− 6 individuals that were not
in the reference set and for the remaining two populations, it contained the unique
individual that was not in the reference set.
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Lastly, to summarize imputation performance in each population, we estimated
allelic imputation accuracy using eq. 1 of Huang et al. (2009b), which employs MACH-
estimated genotype posterior probabilities and averages them across SNPs and across
individuals in the target population sample. Imputation error is then deﬁned as one
minus imputation accuracy. We averaged imputation accuracy across 10 replicates
of our imputation experiment, each time using one of ten randomly selected sets of
reference individuals (the mean across the replicates is plotted in Figure 4.6).
We note that except in three African populations (Iraqw, Sengwer, and Borana)
that have slightly elevated native missing data rates of 0.42%, 0.67% and 0.71%,
the other 60 populations have similarly low rates of natively missing data, ranging
between 0.01% and 0.29% across the 1,272 markers on chromosome 21 (“natively
missing data” refer to data missing prior to our intentional masking of SNPs in the
experimental design; all natively missing data rates were computed using unphased
subsets of our ﬁnal dataset).
Imputation at untyped markers based on Hapmap populations. We next
evaluated the use of HapMap Phase 3 populations as reference data and identiﬁed
optimal reference panels for imputing missing genotypes in the various African pop-
ulations. The same collection of 77 SNPs (∼15% of 517 overlapping SNPs between
the HapMap data and our data) masked in the previous experiment was masked, and
the unphased genotypes of these hidden SNPs were estimated using identical MACH
settings to those in the previous section, except that we modiﬁed the “seed” option
to change the initial random seed used by MACH from its default value of 123456.
The values plotted in Figure 4.7 were obtained as means across 10 replicates, with
the replicates having varying random seeds for the MACH runs. We considered as
reference data combinations of HapMap Phase 3 groups of African origin, pooling
phased genotypes of unrelated individuals from the four populations with signiﬁcant
recent African ancestry (40 ASW, 80 LWK, 96 MKK, and 108 YRI individuals). In
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total, 24 − 1 = 15 possible combinations were considered. Because we combined the
panels with their original sizes, the 15 combination panels varied in size. Imputation
accuracy was assessed in the same manner as in the previous experiment.
Relating imputation to haplotype variation. To explore the relationship
between imputation accuracy and summary statistics on genotypic and haplotypic
variation, we investigated the correlation between maximal imputation accuracy in
the 15 African populations on the basis of the optimal panel chosen among the 15
HapMap combinations and each of several summary statistics: number of private
haplotypes, LD as measured by r2, haplotype sharing as measured by the fraction of
common haplotypes also found in the optimal panel among the 15 choices, and Fst
between a target population and its corresponding optimal mixture of the HapMap
Phase 3 panels. The number of private haplotypes and the fraction of common
haplotypes shared with the HapMap were computed using a window size of 50kb.
Values of r2 were determined using 6kb bins, and Fst was computed for individual
SNPs and then averaged across SNPs. Imputation and haplotype-variation results
were obtained using the same underlying set of 517 SNPs that overlapped between
the HapMap data and our study samples. We computed the Pearson correlation
coeﬃcients between imputation accuracy and each of the four statistics.
4.5 Web Resources
HapMap Phase 3 data,
http://hapmap.ncbi.nlm.nih.gov/downloads/phasing/2009-02_phaseIII/HapMap3_r2/
MACH software, http://www.sph.umich.edu/csg/abecasis/MACH/
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Population Sampling location Language family Sample size
Beja Sudan Afroasiatic 20
Borana Kenya Afroasiatic 18
Fulani Cameroon Niger-Kordofanian 19
Hadza Tanzania Khoesan 18
Iraqw Tanzania Afroasiatic 18
Mada Cameroon Afroasiatic 19
Sandawe Tanzania Khoesan 20
Sengwer Kenya Nilo-Saharan 18
Table 4.1: Eight newly genotyped African populations incorporated in the study.
The Beja and Fulani samples are from the Tishkoﬀ et al. (2009) Hadandawa Beja
and Mbororo Fulani samples, respectively.
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Figure 4.1: Schematic world map of haplotype variation. (A) Haplotype sharing on
the basis of the data from Pemberton et al. (2008). (B) Haplotype sharing after in-
cluding eight newly sampled African populations. The mean number of haplotypes
per genomic core region in a sample size of 54 chromosomes is written for each geo-
graphic region. Links entering a geographic region indicate the percentages of distinct
haplotypes from the geographic region found in other regions and are drawn propor-
tionately in width. For example, in part A, on average 10% of haplotypes observed
in Europe are found in Africa (18% in part B), whereas 6% of African haplotypes
are found in Europe (10% in part B). The links can be viewed as a description of
haplotype “ﬂow”: for example, 10% (18%) gives a measurement of the proportion of
distinct European haplotypes that could have come from Africa (without mutation or
recombination), and 6% (10%) gives the proportion of African haplotypes that could
have come from Europe. We used 1,800 core SNPs to generate the ﬁgure.
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Figure 4.2: Numbers of private haplotypes. (A) The number of private haplotypes in
each geographic region as a function of haplotype length. Sample sizes were adjusted
to represent 54 chromosomes from each geographic region. (B) The number of private
haplotypes in each African population as a function of haplotype length. Sample
sizes were adjusted to represent 12 chromosomes from each population. Error bars
represent the standard error of the mean across haplotype-loci.
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Figure 4.4: The fraction of common haplotypes in individual populations that are
also common in the HapMap. For each plot we used haplotypes based on the 517
SNPs that overlap between HapMap Phase 3 and our autosomal core regions on
chromosome 21. We ﬁrst averaged over all haplotype-loci within each core region
and then averaged across the core regions for windows of a given length. Each curve
shows the fraction of the common haplotypes of a population (with >10% frequency)
that are also common in a HapMap sample.
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Figure 4.5: The fraction of common haplotypes in African populations that are also
common in the HapMap. For each plot we used haplotypes based on the 517 SNPs
that overlap between HapMap Phase 3 and our autosomal core regions on chromosome
21. We ﬁrst averaged over all haplotype-loci within each core region and then averaged
across the core regions for windows of a given length. Each curve shows the fraction
of the common haplotypes of a population (with >10% frequency) that are also
common in a HapMap sample formed by combining speciﬁc HapMap groups with
recent African ancestry. Inside each plot that corresponds to one of the 15 HapMap
mixtures, we label target populations in which the corresponding HapMap mixture
served as the optimal reference panel among the 15 mixture panels. For the last plot
of maximal haplotype sharing with the HapMap, we label the populations with the
highest and lowest maximal sharing fractions.
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Figure 4.6: Imputation accuracy for inference of genotypes at hidden markers. For
each target population speciﬁed by the column label, we masked a set of markers and
imputed genotypes in the population using the reference population speciﬁed by the
row label. Of 1,272 markers, 77, or ∼6%, were randomly chosen among a subset of
517 markers and masked, and for each target, the same set was masked for imputation
with each reference population. The colors correspond to ten deciles of imputation
accuracy across all populations and all reference panels. For each population, the
best and second-best reference panels among 62 other populations are labeled 1 and
2, respectively. For convenience in interpreting the ﬁgure, the horizontal and vertical
blue lines separate results by geographic region (from left to right and from bottom
to top: Africa, Europe, Middle East, Central/South Asia, East Asia, Oceania, and
the Americas).
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of 517 markers as in Figure 4.6.
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Figure 4.8: Imputation accuracy and statistics of genotypic and haplotypic variation.
(A) Number of private haplotypes, (B) linkage disequilibrium as measured by r2, (C)
fraction of common haplotypes also common in the HapMap, and (D) Fst between
a target population and its optimal HapMap mixture. The imputation accuracy
represents the maximal imputation accuracy using the optimal panel among the 15
combinations of the HapMap panels of African descent (identical numerical values as
plotted in Figure 4.7). All computations used the set of 517 SNPs that overlapped
with HapMap Phase 3. In parts A and C, a window size of 50kb was used; in part
B, r2 was computed using a bin size of 6kb; in part D, Fst was ﬁrst computed for
individual SNPs and was then averaged across the 517 SNPs. The fraction of common
haplotypes also found in the HapMap and Fst were computed for target populations
with their respective optimal panels among the 15 choices. The Pearson correlation
coeﬃcients are −0.66 (P = 0.0070) between imputation accuracy and number of
private haplotypes, 0.15 (P = 0.6044) between imputation accuracy and r2, 0.79
(P = 0.0004) between imputation accuracy and fraction of common haplotypes in
a target population also found in the HapMap, and −0.86 (P < 0.0001) between
imputation accuracy and Fst of a target population with its optimal HapMap mixture.
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Figure 4.9: Imputation accuracy and the fraction of common haplotypes that are also
common in the HapMap. For each target population, imputation accuracy using each
of 15 HapMap mixture reference panels is plotted as a function of haplotype sharing
with the reference panel. The imputation accuracy for the optimal reference panel
corresponds to the maximal imputation accuracy plotted in Figure 4.7.
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Figure 4.10: Imputation accuracy and Fst with HapMap mixtures. For each target
population, imputation accuracy using each of 15 HapMap mixture reference panels
is plotted as a function of Fst with the reference panel. The imputation accuracy for
the optimal reference panel corresponds to the maximal imputation accuracy plotted
in Figure 4.7.
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Figure S4.1: Numbers of distinct haplotypes. (A) The number of distinct haplotypes
in each geographic region, and in the pooled worldwide collection, as a function of
haplotype length. Sample sizes were adjusted to represent 54 chromosomes from each
geographic region. (B) The number of distinct haplotypes in each African population,
and in the pooled African population, as a function of haplotype length. Sample
sizes were adjusted to represent 12 chromosomes from each population. Error bars
represent the standard error of the mean across haplotype-loci.
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Figure S4.2: Haplotype heterozygosity in African populations. (A) Haplotype het-
erozygosity in each African population, and in the pooled African population, as a
function of haplotype length. Sample sizes were adjusted to represent 12 chromo-
somes from each population. (B) An ampliﬁcation of the upper right corner of part
A. Error bars represent the standard error of the mean across haplotype-loci.
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CHAPTER V
A Coalescent Model for Genotype Imputation
5.1 Introduction
Over the past few years, the ﬁeld of human genetics has witnessed an explosion in
the number of published genome-wide association (GWA) studies, revealing hundreds
of novel disease-associated genes (Donnelly, 2008; Manolio et al., 2008; Hindorﬀ et al.,
2009, 2011). The considerable potential of GWA studies—which examine thousands
to millions of genetic markers in samples of unrelated individuals with the goal of
uncovering genotype-phenotype correlations—to ultimately improve human health
has been widely recognized (e.g., Pennisi, 2007; Hardy & Singleton, 2009; Manolio,
2010; Stranger et al., 2011).
Among factors contributing to the success of GWA studies is the recent devel-
opment of genotype-imputation methods (Nicolae, 2006; Li et al., 2006; Browning
& Browning, 2007; Marchini et al., 2007; Servin & Stephens, 2007). Genotype im-
putation is a statistical procedure that uses chromosomal stretches shared among
individuals to predict, or impute, genotypes at marker positions not directly mea-
sured in individual GWA studies. The haplotypes of “reference” individuals that
have been genotyped at a higher density than GWA individuals targeted for imputa-
tion often serve as template sequences on the basis of which unknown genotypes in
the targets are inferred. Largely because imputation dramatically increases the num-
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ber of markers that can be interrogated for disease associations and permits larger
sample sizes by enabling data sets typed on diﬀerent platforms to be merged, it has
the potential to increase the statistical power of typical GWA studies (e.g., Li et al.,
2009; Marchini & Howie, 2010). This important role for imputation is likely to persist
as technology advances. It has been suggested that when whole-genome sequencing
of at least a portion of GWA samples becomes feasible for most investigators, impu-
tation will continue to provide a means of improving the power of sequencing-based
GWA studies by imputing in genotyped individuals using sequenced individuals as
templates (Li et al., 2011).
The determinants of genotype-imputation accuracy have recently been examined
empirically in globally distributed human populations (Guan & Stephens, 2008; Pei
et al., 2008; Huang et al., 2009a, 2012; Li et al., 2009; Fridley et al., 2010; Surakka
et al., 2010). These investigations have collectively shown that in imputation-based
GWA studies, population-genetic factors play an important role in determining levels
of imputation accuracy attainable in a study population. Factors such as the overall
level of linkage disequilibrium (LD) in a study population and the degree of genetic
similarity between a study population and a reference population whose members
serve as templates have been found in imputation experiments to be prominent drivers
of imputation accuracy (Egyud et al., 2009; Huang et al., 2009a, 2012; Pas¸aniuc et al.,
2010; Shriner et al., 2010). However, although this body of empirical work on genotype
imputation has provided some understanding of the various population-genetic factors
that aﬀect imputation accuracy, analytical work exploring the theoretical basis for
the ways in which these factors inﬂuence imputation accuracy has been limited.
An analytical approach to studying genotype imputation under a population-
genetic model oﬀers the potential for producing a variety of insights. First, by
obtaining approximate analytical expressions for the mean and variance of impu-
tation accuracy as a function of population-genetic parameters, we can potentially
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explain patterns of imputation accuracy observed in empirical studies in terms of the
population-genetic factors that aﬀect the underlying genealogical relationship between
study and reference individuals. Second, using simple expressions, imputation accu-
racy can be evaluated with less computation than in simulation-based approaches,
enabling investigators to predict imputation accuracy under a model rather than im-
plement computationally intensive simulations. Third, unlike targeted simulations
speciﬁc to particular populations of interest, a general population-genetic modeling
framework can be adapted for organisms beyond humans in which imputation-based
association studies and large-scale genomic resources have begun to emerge (e.g.,
Atwell et al., 2010; Druet et al., 2010; Kirby et al., 2010).
Jewett et al. (2012) recently introduced a theoretical model for evaluating impu-
tation accuracy as a function of population-genetic parameters. Using a coalescent
framework, they analytically studied the eﬀect of reference-panel size on imputation
accuracy, as well as the degree to which use of reference haplotypes from the same
population as a target sequence (an “internal” reference panel) improves the accuracy
of imputation compared to use of reference haplotypes from a separate population
(an “external” reference panel). In order to incorporate a large sample size in ob-
taining their analytical results, however, Jewett et al. (2012) did not account for
randomness in the mutation process. Instead, their treatment of mutation amounted
to an assumption that mutation is a deterministic process, in which mutations accu-
mulate along a genealogical branch in direct proportion to the length of the branch.
Consequently, under this assumption, the best template for imputation is always a
haplotype whose coalescence time with the target sequence on which genotypes are
to be imputed is smallest.
Here, we develop a coalescent model with stochastic mutation, and we use this
model to explore properties of genotype imputation. Assuming the inﬁnite-sites mu-
tation model, we derive the approximate expectation and variance of imputation
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accuracy under a straightforward imputation scheme, conditioning on a mutation pa-
rameter (θ), a proportion of markers genotyped in a given length of a chromosome
(p), and a time to divergence between the target population and an external reference
population (td). A distinguishing feature of our approach from that of Jewett et al.
(2012) is that we explicitly consider a mutation model, thereby allowing for random-
ness in the imputation process that results from the stochasticity of mutation. As in
Jewett et al. (2012), in our derivations, we account for randomness in the genealogy
by considering the distribution of genealogies under a model in which study and ref-
erence individuals are sampled from two populations that diverged at time td in the
past. Under our model, we pose the following questions: (1) What are the inﬂuences
of θ, p, and td on the expectation and variance of imputation accuracy? (2) What is
the expected gain in imputation accuracy in a study sequence targeted for imputa-
tion by using a reference sequence from the same population as the target rather than
from a diﬀerent population? Answers to these questions provide information on the
factors that aﬀect genotype-imputation accuracy, with implications for the design of
imputation-based association studies and the expansion of public genomic databases.
5.2 Theory
In this section, we introduce a theoretical framework that permits the computa-
tion of the approximate expectation and variance of imputation accuracy in a target
sequence on the basis of a reference sequence. The framework has three parts: a
coalescent model that incorporates a mutation process, a decision rule that guides
the selection of a reference sequence for the imputation, and an imputation scheme
that speciﬁes how the imputation is performed. We compute the expectation and
variance of imputation accuracy, conditional on a mutation parameter θ, a propor-
tion p that describes the fraction of sites genotyped in the target sequence, and a
population-divergence time td.
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5.2.1 A Coalescent Model
Consider two populations P1 and P2 that diverged from an ancestral population PA
at time td in the past. Further, consider three haploid individuals—a study individual
targeted for imputation (henceforth simply referred to as a target and denoted by I)
and two reference individuals (denoted by R1 and R2). Reference individual R1
and target individual I are from population P1, and reference individual R2 is from
population P2. In a diploid organism, the haploid individuals can be viewed as single
haplotypes.
For the set of three individuals, let G denote the unobserved random gene tree
labeled topology together with a vector T = (T3, T2, td) of nonnegative elements
that include the unobserved random coalescence times Tk for k = 3, 2 and the ﬁxed
parametric population-divergence time td, where Tk denotes the length of time during
which k distinct lineages exist in the genealogy. We assume that the diploid eﬀective
population size, denoted by Ne, is the same for the two populations P1 and P2 and
their ancestral population PA. We work with coalescent time units so that times are
measured in units of 2Ne generations. For convenience, we hereafter refer to G as
the genealogy. The genealogy G can have one of four possible genealogical types G
(Figure 5.1): three cases in which the ﬁrst coalescent event occurs more anciently
than the population-divergence time td (g = A,B,C), and one in which the ﬁrst
coalescent event occurs more recently than time td (g = D). For each genealogical
type, we label the external branches for the lineages of reference individuals R1 and
R2 and target individual I by 1, 2, and 3, respectively (Figure 5.1).
Throughout this study, we examine the genealogy g backward in time, combining
the external branch immediately descended from the root with the internal branch
immediately descended from the foot into one branch that takes on the label for the
external branch. For instance, branch 2 in genealogy A of Figure 5.1 has length
td + t3 + 2t2. Also note that as shown in Figure 5.1, in genealogies A,B and C, T3
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measures from td back in time, whereas in genealogy D, T3 measures from the present
and thus includes the length td.
Under standard coalescent theory, the time (in units of 2Ne generations) for k
lineages in the same population to coalesce to k − 1 lineages follows an exponential
distribution with parameter
(
k
2
)
(Wakeley, 2008). Thus, in our model, for g = A,B,C
and k = 3, 2, and for g = D and k = 2,
fTk(tk;G = g, td) =
(
k
2
)
e−(
k
2)tk , (5.1)
where Tk is measured in units of 2Ne generations (Figure 5.1). For g = D and k = 3,
the two lineages in population P1—reference individual R1 and target individual I—
must coalesce before, or no more anciently than, the divergence time td (their ancestral
lineage then coalesces with reference individual R2 in the ancestral population PA).
Hence, given genealogy D and time td, the probability density function for the time
T3 to coalescence from three to two lineages is
fT3(t3;G = D, td) =
e−t3
1− e−td 1{t3<td}, (5.2)
where T3 is measured in units of 2Ne generations.
The genealogical type G is an unobserved random variable, and we next obtain its
probability mass function for use in later computations. More speciﬁcally, we compute
the probability P(G = g|td) for g = A,B,C,D by conditioning on the location of
the coalescence of reference individual R1 and target individual I. Considering the
lineages backward in time, we deﬁne E to be the event that R1 and I do not coalesce
by td and E¯ to be the event that R1 and I do coalesce before td. We assume that each
pair of lineages in the same population has the same probability of being the ﬁrst to
coalesce. Thus, conditioning on event E , genealogies A, B, and C occur with equal
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probabilities. Therefore,
P(G = g|td) =P(G = g|E , td) · P(E|td) + P(G = g|E¯ , td) · P(E¯ |td)
=
⎧⎪⎨⎪⎩
1
3
· e−td + 0 · (1− e−td) = 1
3
e−td if g = A,B,C
0 · e−td + 1 · (1− e−td) = 1− e−td if g = D.
(5.3)
Stochastic mutation. In this study, we consider only the polymorphic sites in
a sample of three sequences, ignoring all non-polymorphic sites in the sample. We
assume the inﬁnite-sites mutation model with no recombination. Under the inﬁnite-
sites mutation model, the number of polymorphic sites in a sample is the same as
the number of mutations in its gene genealogy, so we use the terms “polymorphic
sites” and “mutations” interchangeably. We denote the population-scaled mutation
parameter by θ = 4NeμL, where μ is the mutation rate per base pair per generation,
and L is the length (in base pairs) of the sequence under consideration. In the
remainder of this section, for any genealogical type g, we specify the distributions
assumed for random variables that we need later for computing the mean and variance
of imputation accuracy.
Let Xi be the unobserved random total number of mutations on branch i under
the neutral coalescent model (i = 1, 2, 3). We assume that with probability p, a given
site is genotyped in the target, and that sites are chosen independently for genotyping.
Reference individuals R1 and R2 are assumed to be genotyped at all sites at which
the set of three lineages is polymorphic. Let Yi be the random number of mutations
on branch i that are genotyped in the target, chosen among all Xi mutations on the
branch. Let hi(T ; g) denote the length of branch i of a given genealogy assumed to
have time T and type g.
The total number of mutations Xi on a branch, conditional on its branch length
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hi(T ; g) follows a Poisson distribution with parameter hi(T ; g)θ/2. That is,
Xi|T , g ∼ Poisson (hi(T ; g)θ/2) , (5.4)
where hi(T ; g) is speciﬁed in Table 5.1 for g = A,B,C,D and i = 1, 2, 3. Because in-
dividual sites are genotyped in the target independently of each other with probability
p, conditional on the total number of mutations Xi on branch i, the random num-
ber of mutations Yi on branch i that are genotyped in the target follows a binomial
distribution with parameters Xi and p,
Yi|Xi ∼ Bin(Xi, p). (5.5)
The unobserved random number of mutations (Xi−Yi) on branch i that are untyped
in the target follows a binomial distribution with parameters Xi and 1− p,
(Xi − Yi)|Xi ∼ Bin(Xi, 1− p). (5.6)
Equations 5.4 and 5.5 imply that
Yi|T , g ∼ Poisson(hi(T ; g)θp/2) (5.7)
(Casella & Berger, 2001, pg. 163). Similarly, equations 5.4 and 5.6 imply that condi-
tional on the coalescence and population-divergence times T , the number of mutations
(Xi − Yi) on branch i that are untyped in the target follows a Poisson distribution
with parameter hi(T ; g)θ(1− p)/2,
(Xi − Yi)|T , g ∼ Poisson(hi(T ; g)θ(1− p)/2). (5.8)
Furthermore, conditional on T the numbers of mutations on any two branches Yi and
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Yj that are genotyped in the target are independent, and the diﬀerence in the two
independent Poisson-distributed variables follows a Skellam distribution (Johnson &
Kotz, 1969). Thus, for i, j = 1, 2, 3 and i = j,
(Yi − Yj)|T , g ∼ Skellam(hi(T ; g)θp/2, hj(T ; g)θp/2), (5.9)
with mean (hi(T ; g)− hj(T ; g))θp/2 and variance (hi(T ; g) + hj(T ; g))θp/2.
5.2.2 A Decision Rule
Recall that in our sample of three haploid individuals—a target I and two ref-
erences R1 and R2, we consider only polymorphic sites. The target individual is
assumed to be genotyped at only a subset of the sites that are polymorphic in the
three individuals. We now further assume that missing genotypes at untyped mark-
ers in the target are substituted and thus imputed with corresponding genotypes in
a chosen reference individual who has been genotyped at all of the sites. The choice
of a reference individual for the imputation is speciﬁed by a decision rule δs that we
introduce below, and the metric that we use for evaluating imputation accuracy is
speciﬁed in Section 5.2.3.
Generally, because imputation relies on the occurrence of chromosomal stretches
that are shared identically by descent between target and reference individuals, we
expect imputation accuracy in a target individual to improve with increased genetic
similarity between the target and reference individuals. We therefore deﬁne a distance
statistic di between reference individual Ri (branch i; i = 1, 2) and target individual
I (branch 3) to be the number of pairwise sequence diﬀerences between the two
individuals at positions genotyped in the target, namely
di := Yi + Y3. (5.10)
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Smaller values of di indicate a greater degree of observed genetic similarity—measured
at the genotyped positions in the target—between reference individual Ri and the
target.
We now present a decision rule (δs) based on the distance statistic di (eq. 5.10)
that we use to select which of the two reference individuals, R1 or R2, is used for
imputation in the target individual. In short, choosing between the two reference
individuals, rule δs selects the genetically more similar reference individual to the
target as measured by the distance statistic (i.e., by the observed number of pairwise
sequence diﬀerences between the reference and the target).
Rule δs
• If d1 < d2, use reference R1.
• If d2 < d1, use reference R2.
• If d1 = d2, with probability 1/2, use reference R1, and with probability 1/2, use
reference R2.
5.2.3 An Imputation Scheme
Once a reference individual is chosen for imputation in the target, we substi-
tute missing genotypes at untyped markers in the target by those at corresponding
positions in the reference. We illustrate the reference selection and the imputation
procedure in Figure 5.2.
We assess imputation accuracy by the proportion of polymorphic sites untyped in
the target that are subsequently imputed correctly on the basis of a chosen reference
individual. Let Ri, i = 1, 2, denote the chosen reference individual, and let Rj, j = i
and j = 2, 1, denote the reference individual that is not chosen. Then, imputation
accuracy obtained on the basis of reference individual Ri is deﬁned as
Z :=
Xj − Yj∑3
=1(X − Y)
. (5.11)
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We note that the denominator
∑3
=1(X − Y) corresponds to the total number of
untyped polymorphic sites in the target that are subsequently imputed, and that
when
∑3
=1(X − Y) = 0, there are no genotypes to impute, rendering Z undeﬁned.
The numerator is Xj − Yj because under the inﬁnite-sites mutation model, among
polymorphic sites, those produced by mutations on the branch corresponding to ref-
erence individual Rj are exactly where reference individual Ri and target individual
I have identical genotypes. Thus, to count the number of polymorphic sites imputed
correctly in the target on the basis of reference individual Ri, one simply counts the
number of mutations on the branch corresponding to reference individual Rj that are
not genotyped in the target but that are imputed.
5.2.4 Approximate Expressions for the Expectation and Variance of Im-
putation Accuracy
At sites genotyped in both reference and target individuals, the number of pairwise
sequence diﬀerences di between reference individual Ri (i = 1, 2) and target individual
I is known. Given di for i = 1, 2, we apply the rule δs in Section 5.2.2 to select a
reference individual for imputing missing genotypes at untyped markers in the target.
Conditioning on the model parameters—the mutation parameter θ, the proportion p
of polymorphic markers genotyped in the target, and the population-divergence time
td—in this section, we derive the approximate expectation and variance of imputation
accuracy Z deﬁned in eq. 5.11 by averaging over all possible genealogical types G and
coalescence times T3 and T2.
To compute the expectation E[Z|θ, p, td], we consider three possible scenarios that
can occur when we apply rule δs to a genealogy: reference individual R1 is selected as
the template sequence for imputation in target individual I because d1 < d2, reference
individual R2 is selected because d1 > d2, and a choice is made probabilistically
between references R1 and R2 because d1 = d2. Let S1 be the scenario in which d1 < d2
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(i.e., Y1 − Y2 < 0), let S2 be the scenario in which d1 > d2 (i.e., Y1 − Y2 > 0), and let
S3 be the scenario in which d1 = d2 (i.e., Y1 − Y2 = 0). We can obtain E[Z|θ, p, td]
by taking a weighted average of its expectation conditional on the genealogical type
g and the scenario Sx, where g = A,B,C,D and x = 1, 2, 3, and where the weight is
the joint probability of the genealogical type G = g and the scenario Sx:
E[Z|θ, p, td] =
∑
g=A,B,C,D
3∑
x=1
E[Z|g,Sx, θ, p, td]P(g,Sx|θ, p, td). (5.12)
We ﬁrst derive the conditional expectations E[Z|g,Sx, θ, p, td] and the probabilities
P(g,Sx|θ, p, td) for g = A,B,C,D and x = 1, 2, 3, and we then obtain the expectation
E[Z|θ, p, td] using eq. 5.12.
All quantities in Sections 5.2.4.1 and 5.2.4.2 are conditional on θ, p and td, but
for notational convenience, these parameters are suppressed.
5.2.4.1 Derivation of E[Z|g,Sx] in eq. 5.12
Let B be a Bernoulli random variable with parameter 1/2. For any genealogical
type g, we can explicitly express the expectation E[Z|g,Sx] under a speciﬁc scenario
Sx for x = 1, 2, 3 as follows:
E[Z|g,Sx] =
⎧⎪⎪⎨⎪⎪⎩
E
[
Xj−Yj
∑3
=1(X−Y)
∣∣∣∣g,Sx] for x, j = 1, 2 and j = x
E
[
b X2−Y2∑3
=1(X−Y)
+ (1− b) X1−Y1∑3
=1(X−Y)
∣∣∣∣g,Sx] for x = 3. (5.13)
For computational convenience, to obtain E[Z|g,Sx], we use the ﬁrst-order Taylor-
series approximation and an additional approximation of E[Xj − Yj|g,Sx] by E[Xj −
Yj|g]. That is, for g = A,B,C,D, x, j = 1, 2, and j = x,
E[Z|g,Sx] = E
[
Xj − Yj∑3
=1(X − Y)
∣∣∣∣g,Sx
]
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≈ E[Xj − Yj|g,Sx]
E[
∑3
=1(X − Y)|g,Sx]
(5.14)
≈ E[Xj − Yj|g]
E[
∑3
=1(X − Y)|g]
, (5.15)
and for g = A,B,C,D and x = 3,
E[Z|g,Sx] =1
2
(
E
[
X2 − Y2∑3
=1(X − Y)
∣∣∣∣g,Sx
]
+ E
[
X1 − Y1∑3
=1(X − Y)
∣∣∣∣g,Sx
])
(5.16)
≈1
2
(
E[X2 − Y2|g,Sx]
E[
∑3
=1(X − Y)|g,Sx]
+
E[X1 − Y1|g,Sx]
E[
∑3
=1(X − Y)|g,Sx]
)
(5.17)
≈1
2
(
E[X2 − Y2|g]
E[
∑3
=1(X − Y)|g]
+
E[X1 − Y1|g]
E[
∑3
=1(X − Y)|g]
)
. (5.18)
In eqs. 5.15 and 5.18, for g = A,B,C,D and i = 1, 2, 3, the expectation E[Xi−Yi|g]
can be found by conditioning on the coalescence times T3 and T2 and then integrating
over their distributions:
E[Xi − Yi|g] =
∫ ∞
t2=0
∫ a
t3=0
E[Xi − Yi|t3, t2, g] · fT3,T2(t3, t2|g) dt3 dt2. (5.19)
As the expectation of a Poisson random variable,
E[Xi − Yi|t3, t2, g] = hi(T ;g)θ(1− p)/2. (5.20)
In any genealogy, by the independence of coalescence times under the coalescent
model,
fT3,T2(t3, t2|g) = fT3(t3|g) · fT2(t2|g), (5.21)
where fT3(t3|g) and fT2(t2|g) are evaluated using eqs. 5.1 and 5.2. The upper limit of
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the inner integral in eq. 5.19 depends on the genealogy under consideration; that is,
a =
⎧⎪⎨⎪⎩ ∞, if g = A,B,Ctd, if g = D. (5.22)
This completes the derivation of E[Z|g,Sx] in eq. 5.12, and we now derive P(g,Sx).
5.2.4.2 Derivation of P(g,Sx) in eq. 5.12
We compute the probability P(g,Sx) by jointly considering the marginal distribu-
tion of g and the conditional distribution of Sx given a genealogical type G = g:
P(g,Sx) =P(g) · P(Sx|g). (5.23)
The probability P(g) is given in eq. 5.3. As in the derivation of the expectation
E[Xi − Yi|g] in eq. 5.19, to compute P(Sx|g), we ﬁrst condition on the coalescence
times T3 and T2 and then integrate over their distributions:
P(Sx|g) =
∫ ∞
t2=0
∫ a
t3=0
P(Sx|t3, t2, g) · fT3,T2(t3, t2|g) dt3 dt2, (5.24)
where a is given in eq. 5.22, P(Sx|t3, t2, g) can be obtained by considering the diﬀerence
Y1−Y2 and using eq. 5.9, and fT3,T2(t3, t2|g) can be computed using eqs. 5.1, 5.2, and
5.21.
This completes the derivation of the expectation E[Z] in eq. 5.12.
5.2.4.3 Derivation of Var[Z|θ, p, td]
We ﬁrst note that we can obtain Var[Z|θ, p, td] using the following equation:
Var[Z|θ, p, td] = E[Z2|θ, p, td]− E[Z|θ, p, td]2, (5.25)
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where E[Z|θ, p, td] is as derived above (eq. 5.12). It remains to derive E[Z2|θ, p, td].
As in the derivation of the expectation E[Z|θ, p, td] (eq. 5.12), we obtain the ex-
pectation E[Z2|θ, p, td] by conditioning on the genealogical type g and the scenario
Sx, where g = A,B,C,D and x = 1, 2, 3:
E[Z2|θ, p, td] =
∑
g=A,B,C,D
3∑
x=1
E[Z2|g,Sx, θ, p, td]P(g,Sx|θ, p, td). (5.26)
Because the derivation of E[Z2|θ, p, td] (eq. 5.26) is similar to that of E[Z|θ, p, td]
(eq. 5.12), we omit it to avoid redundancy. The main diﬀerence in the derivation
here is the ﬁrst-order Taylor series approximation for the variance Var[Z|g,Sx, θ, p, td]
needed in estimating the expectation E[Z2|g,Sx, θ, p, td] in eq. 5.26:
Var[Z|g,Sx, θ, p, td] =Var
[
Xj − Yj∑3
=1(X − Y)
∣∣∣∣g,Sx, θ, p, td
]
≈
(
E[Xj − Yj|g,Sx, θ, p, td]
E[
∑3
=1(X − Y)|g,Sx, θ, p, td]
)2(
Var[Xj − Yj|g,Sx, θ, p, td]
E[Xj − Yj|g,Sx, θ, p, td]2
+
Var[
∑3
=1(X − Y)|g,Sx, θ, p, td]
E[
∑3
=1(X − Y)|g,Sx, θ, p, td]2
− 2Cov(Xj − Yj,
∑3
=1(X − Y)|g,Sx, θ, p, td)
E[Xj − Yj|g,Sx, θ, p, td]E[
∑3
=1(X − Y)|g,Sx, θ, p, td]
)
(Casella & Berger, 2001, pg. 245). The quantity P(g,Sx|θ, p, td) in eq. 5.26 is obtained
as in Section 5.2.4.2.
5.3 Methods of Computation and Simulation
To calculate the expectation E[Z|θ, p, td] (eq. 5.12) in practice, we obtain ap-
proximations for E[Z|g,Sx, θ, p, td] using eqs. 5.15 and 5.18 and the Monte Carlo
estimates of P(Sx|g, θ, p, td) involved in the expression of P(g,Sx|θ, p, td). To compute
the variance Var[Z|θ, p, td] (eq. 5.25), we further approximate E[Z2|g,Sx, θ, p, td] in
eq. 5.26. Finally, to verify the approximate analytical expressions of E[Z|θ, p, td] and
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Var[Z|θ, p, td] in eqs. 5.12 and 5.25, using the algorithm below, we performed simula-
tions to obtain simulated means and variances of imputation accuracy that we then
compared to our estimates of E[Z|θ, p, td] and Var[Z|θ, p, td].
Algorithm for estimating E[Z|θ, p, td] and Var[Z|θ, p, td] through simulation
1. Set parameter values for θ, p, and td.
2. For m = 1 to M :
(a) Generate a genealogical type G using a uniformly distributed random variable
U ∼ Uniform(0, 1). If u < 1 − e−td , set g = D. Otherwise, generate u′ from
Uniform(0, 1), independently of u. Set g = A if u′ ∈ [0, 1/3), set g = B if
u′ ∈ [1/3, 2/3), and set g = C if u′ ∈ [2/3, 1).
(b) Generate a coalescence time T2 ∼ Exp(1).
(c) If g = A,B,C, generate a coalescence time T3 ∼ Exp(3). Otherwise, generate
T3 from the probability density function in eq. 5.2.
(d) For i = 1, 2, 3, generate a total number of mutations Xi ∼ Poisson(hi(T ; g)θ/2)
on branch i, where T = (t3, t2, td) and hi(T ; g) is speciﬁed in Table 5.1.
(e) For i = 1, 2, 3, given Xi, sample the number of mutations on branch i that are
genotyped in the target as Yi|Xi = xi ∼ Binomial(xi, p).
(f) If
∑3
i=1(xi − yi) = 0, return to (b); otherwise, continue.
(g) If y1 − y2 < 0 (i.e., if d1 < d2), compute z(m) = x2−y2∑3
i=1(xi−yi)
.
(h) If y1 − y2 > 0 (i.e., if d2 < d1), compute z(m) = x1−y1∑3
i=1(xi−yi)
.
(i) If y1 − y2 = 0 (i.e., if d1 = d2), generate b from Bernoulli(1/2). Compute
z(m) =
x2−y2∑3
i=1(xi−yi)
if b = 1 and z(m) =
x1−y1∑3
i=1(xi−yi)
otherwise.
3. Compute the sample mean z¯ and the sample variance s2 that respectively represent
simulation-based estimates of E[Z|θ, p, td] and Var[Z|θ, p, td], where z¯ = 1M
∑M
m=1 z(m)
and s2 = 1M−1
∑M
m=1(z(m) − z¯)2.
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5.4 The Role of the Parameters
Figures 5.3A and 5.3B separately plot the expected imputation accuracy E[Z|θ, p, td]
as a function of the mutation rate θ and the proportion p of polymorphic sites that are
genotyped in a target sequence. For the parameter values considered, the theoretical
approximations of E[Z|θ, p, td] obtained using eq. 5.12 closely match the simulated
averages of imputation accuracy, although the theoretical approach tends to produce
smaller values than the simulation for most parameter values considered in Figure
5.3.
The observed underestimation of the theoretical estimates of E[Z|θ, p, td] by eq. 5.12
can possibly be attributed to the Taylor series approximation for the expectation
E[Z|g,Sx, θ, p, td] (eqs. 5.14 and 5.17) and to the additional approximation of E[Xi −
Yi|g,Sx, θ, p, td] by E[Xi − Yi|g, θ, p, td] in estimating E[Z|g,Sx, θ, p, td] (eqs. 5.15 and
5.18). However, at p = 0 when only the Taylor series approximation has an eﬀect,
there is no evidence of such underestimation (Figure 5.3A), suggesting that the under-
estimation is primarily due to the additional approximation E[Xj−Yj|g,Sx, θ, p, td] ≈
E[Xj − Yj|g, θ, p, td]. In this additional approximation, for ease of computation, we
ignore the condition Sx in calculating the expected values of the number of sites cor-
rectly imputed in the target, Xj −Yj (i.e., the numerator of the imputation-accuracy
statistic Z). However, Sx provides information about which reference individual has
fewer pairwise sequence diﬀerences with the target. Therefore, knowing Sx leads
one to expect higher imputation accuracy than not knowing the condition, and dis-
regarding Sx in our approximation may be partially responsible for the observed
underestimation.
The mutation parameter θ plays an important role in determining imputation
accuracy in a target sequence, as long as the proportion of polymorphic sites that
are genotyped in the target p is non-zero. More speciﬁcally, for p > 0, expected
imputation accuracy increases as θ increases, whereas for p = 0, expected imputation
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accuracy stays constant as θ increases (Figure 5.3A). When p > 0, increasing θ in-
creases the number of pairwise sequence diﬀerences between each reference sequence
and the target. The larger sequence diﬀerences in turn enable a more accurate deter-
mination of which reference sequence is genetically more similar to the target.
When p is small, compared to the case in which p is large, the expected imputation
accuracy increases more steadily as θ increases from 1 to 10 (Figure 5.3A). Consider
the total increase in the expected imputation accuracy as θ increases from 1 to 10.
This increase is comparable for p = 0.1 and p = 0.9 (0.0858 and 0.0877, respectively);
while ﬁfty percent of such increase do not occur until θ ∈ (4, 5) for p = 0.1, they
occur by θ ∈ (2, 3) for p = 0.9. This result suggests that at small values of θ, the
rate of increase in the expected imputation accuracy due to an increase in θ is slower
for a small, rather than large, value of p. In other words, when the proportion p of
polymorphic sites that are genotyped in the target is small, the eﬀect of the mutation
parameter θ on imputation accuracy is less pronounced than when p is large.
The proportion p of polymorphic sites that are genotyped in a target sequence
also plays an important role in determining imputation accuracy in the target. As p
increases, imputation accuracy increases in expectation (Figure 5.3B). We again oﬀer
the intuitive explanation that increased p implies increased information for selecting a
reference sequence that has an increased probability of being more genuinely similar
to the target. For each θ that we considered, the rate of increase in the expected
imputation accuracy due to an increase in p is faster when p is small than when p is
large. This result is consistent with empirical observations of Fridley et al. (2010),
who found that in a candidate gene sequencing study, imputation accuracy improved
with an increase in the number of markers genotyped in the target and that the
improvement was most pronounced when the initial number of genotyped markers
was smallest.
Figures 5.4A and 5.4B separately plot the variance in imputation accuracy Var[Z|θ, p, td]
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as a function of θ and p. Except when θ is small (e.g., θ ≤ 4) or when p is large (e.g.,
p > 0.5), the theoretical estimates of Var[Z|θ, p, td] obtained using eq. 5.25 closely
match the simulated variances. Further, we ﬁnd that the variance of imputation accu-
racy increases with decreasing θ and with increasing p. This increase occurs because
decreasing θ and increasing p reduce the number of polymorphic sites that need to be
imputed in the target, thereby producing a larger variance in the statistic measuring
imputation accuracy.
For two values of the divergence time td between the target and reference popu-
lations (td = 0 and td = 0.1), Figures 5.5A and 5.5B separately plot the approximate
expected imputation accuracy E[Z|θ, p, td] as a function of θ and p. For both values
of td, expected imputation accuracy increases with increasing θ and p. Moreover, for
given values of θ and p, expected imputation accuracy also increases as td increases.
This is because with increasing td, there is more time for mutations to accumulate
along each branch, on average. For ﬁxed values of θ and p, an increase in the oc-
currence of mutations leads to an increase in the number of polymorphic sites that
are genotyped in the target, again allowing a more accurate determination of the
reference sequence that is genetically more similar to the target.
For td = 0 and td = 0.1, Figures 5.6A and 5.6B separately plot the approximate
variance of imputation accuracy Var[Z|θ, p, td] as a function of θ and p. For both val-
ues of td, we observe the same patterns of increasing variance in imputation accuracy
with decreasing θ and increasing p.
To assess the expected gain in imputation accuracy in a target sequence by using
a reference sequence from the same population as the target (i.e., reference sequence
R1) rather than from a diﬀerent population (i.e., reference sequence R2), for td = 0.1
and td = 0.01, we plotted the simulated mean imputation accuracies in the target
for each scenario separately in Figure 5.7A. The simulation procedure was modiﬁed
to produce the results in both plots of Figure 5.7, with steps (g)-(i) replaced by a
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single step of computing z(m) =
x2−y2∑3
i=1(xi−yi)
for the case in which R1 is always used as
the template and z(m) =
x1−y1∑3
i=1(xi−yi)
otherwise. The diﬀerence in the mean accuracies
between the imputations performed using R1 and the imputations performed using
R2 remains fairly constant over a wide range of parameter values considered for θ
and p (Figure 5.7B). Denote the mean value of this diﬀerence by Δtd . Then, for
θ = 1, 2, · · · , 10 and p = 0, 0.1, 0.5, 0.9, Δ0.1 = 0.0829 and Δ0.01 = 0.0099 based on
simulations. Surprisingly, we can estimate these mean diﬀerences quite accurately
using a simple formula:
Δ̂td =
2E[T2|G = D, td] + 2td − 2E[T3|G = D, td]
2E[T2|G = D, td] + 2td + E[T3|G = D, td] P(G = D|td), (5.27)
where E[T2|G = D, td] and E[T3|G = D, td] are found using eqs. 5.1 and 5.2, respec-
tively, and where P(G = D|td) = 1− e−td is given in eq. 5.3. We obtain that for any
td ≥ 0,
E[T2|G = D, td] = 1 (5.28)
and
E[T3|G = D, td] =
∫ td
0
t3
e−t3
1− e−td dt3 =
1− (1 + td)e−td
1− e−td . (5.29)
Evaluating all the terms involved in Δ̂td (eq. 5.27) at td = 0.1 and td = 0.01, we have
Δ̂0.1 = 0.0889 and Δ̂0.01 = 0.0099.
To show that use of reference sequence R1 always results in higher imputation
accuracy in the target, on average, than use of reference sequence R2, we prove here
Δ̂td ≥ 0 by noting that the numerator and denominator of Δ̂td (eq. 5.27) are positive
numbers. This is because in genealogy D, times T2, T3, and td must be non-negative,
and T3 must be smaller than or equal to td (see Figure 5.1). Therefore, in eq. 5.27,
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the numerator
2{E[T2|G = D, td] + (td − E[T3|G = D, td])} > 2{0 + 0} > 0,
and the denominator
2{E[T2|G = D, td] + td}+ E[T3|G = D, td] > 2{0 + 0}+ 0 > 0.
5.5 Discussion
We have introduced a theoretical framework for investigating genotype imputa-
tion and the various population-genetic factors that aﬀect imputation accuracy. The
framework includes a two-population coalescent model for three sequences, and a
mutation model to account for stochasticity in the mutation process and thus in
the choice of imputation template. Using this framework and a simple imputation
scheme, we have derived approximate expressions for the expectation and variance of
the accuracy of imputation in the target sequence using a reference sequence chosen
on the basis of observed genetic similarity to the target at genotyped positions.
The three parameters of the coalescent model are the mutation parameter θ, the
proportion p of polymorphic sites in a chromosomal region that are genotyped in the
target, and the divergence time td between the two populations. Measuring impu-
tation accuracy by the proportion of polymorphic sites that are untyped but subse-
quently imputed correctly in the target, we found that imputation accuracy increases
in expectation with increasing θ, p, and td. We also observed that the variance in im-
putation accuracy decreases with increasing θ and td, and that the variance increases
with increasing p. Additionally, we found that under the model, the expected gain in
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accuracy when the reference sequence R1, rather than the reference sequence R2, is
used can be accurately predicted by a simple formula relating the expected diﬀerence
in imputation accuracy to the expected diﬀerence in branch lengths of R1 and R2
(eq. 5.27).
Our results on the trends in the expected imputation accuracy can be explained
intuitively by considering the amount of information available for determining which
of the two reference sequences, R1 or R2, is genetically more similar to the target. For
instance, increasing the mutation parameter θ = 4NeμL can be considered equivalent
to increasing the length L of the chromosomal region under consideration, when the
eﬀective population size Ne and the mutation rate μ per base pair per generation
are held constant. For any p and td, comparing genotypes at a ﬁxed proportion
p of markers in longer target and reference sequences rather than in shorter ones
increases the probability that the reference sequence that is truly genetically more
similar to the target at typed and untyped markers alike in the region of interest can
be identiﬁed. An increase in the probability of correctly identifying the genetically
more similar reference sequence, and therefore using it for imputation, leads to an
increase in expected imputation accuracy.
We conclude with a discussion of model limitations. Because of the complexity in
computing the expectation and variance of imputation accuracy, we have restricted
our attention to a simple two-population demographic model and a sample size of
three sequences. We have also made simplifying assumptions that (1) the two pop-
ulations and their ancestral population have equal eﬀective population sizes Ne, (2)
no migration occurs more recently than the population-divergence time, and (3) no
mutation occurs at a nucleotide that has previously experienced a mutation (i.e.,
the inﬁnite-sites mutation model). Furthermore, we have assumed a straightforward
imputation scheme that copies and pastes an entire genomic region of interest in a
template reference sequence into the corresponding positions in the target sequence,
127
rather than allowing diﬀerent templates in diﬀerent genomic regions. Each of these
assumptions is unlikely to be completely realistic for potential studies in human pop-
ulations. Nevertheless, the simplicity of our modeling framework has enabled us to
analytically study patterns of imputation accuracy that provide insights into the ways
in which individual population-genetic factors inﬂuence imputation accuracy. These
insights, along with continuing development of coalescent-based models for studying
genotype imputation, can lead to further insights regarding the performance of impu-
tation methods, and eventually, to advanced strategies for the design of imputation-
based association studies in humans and other organisms.
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Branch
Topology 1 2 3
A td + t3 td + t3 + 2t2 td + t3
B td + t3 + 2t2 td + t3 td + t3
C td + t3 td + t3 td + t3 + 2t2
D t3 2td − t3 + 2t2 t3
Table 5.1: Branch lengths hi(T ; g) (in units of 2Ne generations) for genealogical types
g = A,B,C,D and branches i = 1, 2, 3 under the two-population model illustrated in
Figure 5.1.
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Figure 5.1: Four possible genealogical types for a set of three haploid individuals
(a candidate reference individual R1 and an individual I targeted for imputation
from one population, and another candidate reference individual R2 from a second
population). The two populations diverged from an ancestral population at time td
in the past, and tk (k = 3, 2) is the length of time during which k distinct lineages
exist. Note that in the genealogical types A,B and C, t3 counts from td back in time,
whereas in the genealogical type D, T3 counts from the present.
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A. Example genealogy with mutations
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B. Schematic of the full data for the genealogy in panel A
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C. Genotype imputation and imputation accuracy
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reference R1 for imputation in target I.
1.
2.
Copying reference R1
into target I yields 1 out
of 4 correctly imputed
genotypes in the target.
Suppose we have the full data, including
the target’s true genotypes at its untyped
markers.
We can then measure accuracy of imputation
in the target on the basis of the chosen
reference R1 by
i.e., the proportion of polymorphic
sites that are untyped but that are subsequently
imputed correctly in the target.
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at untyped markers in the target.
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Figure 5.2: Schematic of our imputation procedure. (A) An example genealogy with
mutations. (B) A schematic of the full data for the genealogy in (A). (C) An illus-
tration of our imputation procedure. In (B) and (C), white and grey colors indicate
ancestral and derived alleles, respectively, and thick black lines indicate genotyped
positions in the target. 131
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Figure 5.3: The expectated imputation accuracy for various values of a mutation pa-
rameter θ and a proportion p of genotypes that are genotyped in the target individual.
For td = 0.1, we obtained theoretical estimates of E[Z|θ, p, td] using eq. 5.12 (solid
line). For N = 105 and td = 0.1, we simulated genealogies G using the algorithm in
Section 5.3 to obtain z¯, which correspond to Monte Carlo estimates of E[Z|θ, p, td]
(dashed line). We then separately plotted ̂E[Z|θ, p, td] and z¯ as functions of θ and
p. The values of θ and p considered were {θ : 1, 2, . . . , 10} and {p : 0, 0.1, 0.5, 0.9}.
For visual clarity, results are displayed for only selected values of θ when plotted as
a function of p. For both plots in this ﬁgure, results were obtained from a shared set
of simulations.
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Figure 5.4: The variance of imputation accuracy for various values of θ and p. For
td = 0.1, we obtained theoretical estimates of Var[Z|θ, p, td] using eq. 5.25 (solid line).
For N = 105 and td=0.1, we simulated using the algorithm in Section 5.3 to obtain
s2, which correspond to Monte Carlo estimates of Var[Z|θ, p, td] (dashed line). We
then plotted ̂Var[Z|θ, p, td] and s2 as functions of θ and p, separately. The values of
θ and p considered were {θ : 1, 2, . . . , 10} and {p : 0, 0.1, 0.5, 0.9}. For visual clarity,
results are displayed for only selected values of θ when plotted as a function of p.
Results of both plots in this ﬁgure were obtained from the same simulation as that
used to obtain Figure 5.3.
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Figure 5.5: The expected imputation accuracy plotted separately (A) as a function
of θ and (B) as a function of p for population-divergence times td = 0.1 and td = 0.
In both plots, results for td = 0.1 (solid line) and td = 0 (dashed line) were obtained
from the same simulation, with the former values of z¯ taken directly from Figure 5.3.
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Figure 5.6: The variance of imputation accuracy plotted separately (A) as a function
of θ and (B) as a function of p for td = 0.1 and td = 0. In both plots, results for
td = 0.1 (solid line) and td = 0 (dashed line) were obtained from the same simulation,
with the former values of s2 taken directly from Figure 5.4.
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Figure 5.7: The expected accuracy for the imputations separately performed using
R1 and R2 as the reference sequence, as well as their pointwise diﬀerences, plotted
as a function of p for td = 0.1 and td = 0.01. In both plots, results for td = 0.1 and
td = 0.01 were obtained from the same simulations used to obtain Figure 5.3.
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CHAPTER VI
Conclusion
Genome-wide association (GWA) studies and genotype imputation are two im-
portant approaches for elucidating association between genetic variants and complex
human diseases. GWA studies, in which several hundred thousand to more than a
million genetic markers are assayed in hundreds or thousands of individuals, rep-
resent a powerful tool for investigating genetic factors that individually make only
small contributions to disease risk. Genotype imputation further allows the evalua-
tion of disease associations at marker positions beyond those measured in individual
GWA studies by leveraging information in reference databases of dense genomic data.
The success of imputation-based GWA studies has been demonstrated for European
populations, in which most discoveries of genes inﬂuencing complex phenotypes have
occurred. In this dissertation, to extend GWA eﬀorts outside European populations,
I studied the design of reference datasets for use in imputation-based genetic associ-
ation studies that seek to identify disease-predisposing genes in human populations
worldwide.
In Chapter II, using dense genotype data from 29 worldwide human populations,
I assessed imputation performance in diverse populations and devised an imputation
strategy for populations that are poorly represented in existing reference datasets. I
showed that the novel imputation strategy—inspired by the unique ancestral histo-
137
ries of individual populations—increases imputation accuracy in all 29 populations,
thereby increasing the potential of GWA studies for uncovering disease-associated
genes in these groups. However, I also found that African populations have lower im-
putation accuracy, suggesting that genomic resources must be expanded for studies
in these populations.
In Chapter III, to assess the consequences of imputation error, considering a 2×3
chi-squared test of association, I related imputation error rates to statistical power
across the same collection of 29 human populations examined in Chapter II. Unex-
pectedly, I found that each 1% rise in the error rate requires a substantial increase
in the minimal sample size (5-13%) to maintain power. This result suggests that the
continuing development of statistical and genomic resources that reduce imputation
error will likely translate into substantially reduced sample sizes needed for detecting
risk-modifying genes in imputation-based studies of complex diseases.
In Chapter IV, focusing on African populations, I investigated haplotype varia-
tion and imputation in Africa, using 253 individuals from 15 Sub-Saharan African
populations. Using various statistics on haplotype variation in Sub-Saharan African
populations to explain genotype-imputation accuracy observed in the same popula-
tions, I found the statistics that measure genetic distance between a target population
and candidate reference populations, such as Fst, to be useful metrics for guiding the
selection of appropriate reference panels for imputation in the target population.
In Chapter V, to analytically study properties of genotype imputation, I developed
a coalescent model for evaluating imputation accuracy in terms of population-genetic
and study-design parameters. Using this model and a straightforward imputation
scheme, I derived the expectation and variance of imputation accuracy, conditioning
on a mutation parameter, a proportion of markers genotyped in a given length of
a study chromosome, and a time to divergence between study and reference popu-
lations. Consistently with prior expectations, the model predicts that on average,
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imputation accuracy increases with increasing information for determining, among
candidate reference sequences, the reference sequence that is genetically closest to a
study sequence targeted for imputation. Interestingly, the model also predicts dimin-
ishing returns in improving imputation accuracy from increasing the proportion of
markers that are genotyped in a chromosomal region of the study sequence. These re-
sults can inform the design of imputation-based association studies and the expansion
of public genomic databases.
In summary, this dissertation concerns the development of optimal genotype-
imputation strategies for the analysis of large-scale genetic association studies in
diverse human populations. My empirical and theoretical ﬁndings have the potential
to considerably improve the design of genetic studies in populations that are poorly
represented in existing public resources. Indeed, results and insights derived from
Chapters II and III have aided the identiﬁcation of multiple novel genetic variants in
the gene TMPRSS6 that aﬀect hemoglobin levels in individuals of Indian ancestry
(Chambers et al., 2009), as well as genetic variants that contribute to the risk of
schizophrenia in subjects of African American ancestry (Shi et al., 2009). In both the
study of Chambers et al. (2009) and that of Shi et al. (2009), consistent with our rec-
ommendations, two or more HapMap populations were pooled together to form the
appropriate reference panels. Additionally, these chapters have provided arguments
for the development of public genomic databases in Mexican and Southeast Asian
populations (Silva-Zolezzi et al., 2009; Teo et al., 2009). Chapters IV and V have
explored the empirical and theoretical basis for the ways in which population-genetic
and study-design parameters inﬂuence imputation accuracy, further strengthening
the foundation for extending imputation-based association study techniques to popu-
lations that have not yet been extensively examined. It is greatly hoped that results
from this dissertation will continue to facilitate the search for genetic determinants
that inﬂuence disease risk in humans.
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